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INTRODUCTION 
Neutrophil Function 
Native immune mechanisms are those which are naturally present in 
the body and have not been induced by vaccination or exposure to 
infectious agents. Native immune factors include serum canponents 
su9h as canplement, lysozyme, B-lysins, and the phagocytic activity of 
neutrophils and macrophages. These factors are especially important 
in the early stages of infection, and are mechanistically canplex 
since they involve the interaction of cellular and humeral canponents 
(75) • 
There are tw main types of "professional" phagocytic cells. 
These are the mononuclear phagocytes, the monocytes and macrophages, 
and the polymorphonuclear leukocytes, the neutrophils and eosinophils 
(71). ·The neutrophil is a highly specialized cell whose primary 
function is to ingest and kill invading microorganisms (8,48,71). 
Neutrophils represent the first line of defense against foreign and 
pathogenic elements and are the first cells to arrive at a site of 
infection (71,73). They must be able to detect invasion of the body, 
move toward the site of invasion, and accumulate at sites of injury or 
infection. This phenomenon, begun by the detection of soluble 
factors, is termed directed locanotion or chemotaxis. t1:>st neutrophil 
chemotactic stimuli are soluble factors which cause the neutrophil to 
move up a concentration gradient of the stimulating factor (71). 
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Circulating neutrophils accumulate at inflanunatory sites because 
of increased endothelial stickiness, attachment to capillary walls, 
and migration into tissues. Chemotactic substances are produced by 
miroorganisms. The best known is the peptide N-formylmethionine which 
is similar to the synthetic peptide n-formyl-methionyl-leucyl-
phenylalanine (fMLP) used in chemotactic studies. Most chemotactic 
substances are produced by either the classic or alternate complement 
pathways. The csa fragment is the most potent chemotactic factor 
derived from the complement pathways (14). 
At the site of infection, neutrophils phagocytize and destroy 
invading microorganisms. Phagocytosis is composed of four phases: 
chemotaxis, opsonization, ingestion, and killing. The migrating 
neutrophil has a characteristic morphology. The leading edge of the 
pseudopod is free of granules but filled with actin microfilaments. 
The actin extends as a thin layer around the cell and occurs as dense 
bundles in the trailing edge of the neutrophil. The actin provides 
structural sUp];X)rt and together with myosin can contract and provide 
cell movement. The energy for cell movement comes from anaerobic 
glycolysis. Microtubules are present, but are not involved in 
motility. They increase cell rigidity and stabilize cell shape while 
serving as an internal "skeleton" (14,84). Microtubules may also be 
involved with movement within the cell itself (79). 
Agents which impair microtubule function in vitro .(e.g. 
colchicine) will cause an enhancement of neutrophil random migration 
and an inhibition of degranulation (71). The randan migration of 
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neutrophils under agarose, as measured by the number of cells leaving 
the well, is enhanced when microtubule inhibiting agents are used. In 
one experiment, incubating neutrophils with concentrations of 
colchicine above 5 x 10-7 M increased the number of cells migrating 
and decreased the mean number of centriolar microtubules in a dose-
dependent fashion from 16 to 4 per um2 at 10-5 M, but the distance of 
migration from the well was not significantly different from non-
colchicine treated human neutrophils. Colchicine acts by decreasing 
peripheral microtubules. The data in this experiment suggest that 
microtubules play a constraining role within the cell, limiting the 
ability of the cell to move and change direction (69). 
The interaction of a microorganism with the neutrophil cell 
membrane is the crucial step in initiating the events which result in 
phagocytosis and elimination of that microorganism. The interaction 
can be facilitated by the presence of heat stable opsonins found 
primarily in the IgG fraction of serum (50). Neutrophils bear Fe 
receptors to which antibody-coated particles adhere (15). 
Opsonization makes bacteria more susceptible to ingestion by 
neutrophils. This can be accomplished by reaction of microorganisms 
with specific antibody alone (especially IgG), specific antibody (IgG 
or IgM) acting with complement in the classical pathway, or 
nonspecifically via the alternate complement pathway. In this third 
method, opsonization occurs without antibody by complement activation 
by bacterial polysaccharides resulting in fixation of C3 (14). 
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Ingestion occurs after opsonization of a microorganism. The 
motion involved in phagocytosis occurs by the same actin-myosin system 
described for chernotaxis. Since the energy needed canes from 
anaerobic glycolysis, phagocytosis can take place even under the 
anaerobic conditions of an abcess. The· sequential interaction of 
opsonic ligands on ·the microbial surface and receptors on the 
phagocyte membrane results in the "zippering" up of particles as they 
are engulfed by pseudopodia. Pseudopodia fuse around ingested 
particles, forming a phagosome, and the microtubules are involved in 
its movement toward the center of the cell (14,84). Microtubules 
could provide a "tracking" mechanism for neutrophil phagosomes. There 
is a convergence of microtubules toward phagosomes and an alignment of 
granules along the microtubules. Several functional interpretations 
can be offered for this possible microtubule "tracking" mechanism: (1) 
granules from the center of the cell may move along microtubules 
towards the peripherally located phagocytic vacuole, (2) microtubules 
aid in the movement of the peripheral phagocytic vacuole towards the 
granule-rich center, (3) the phagocytic vacuole is carried into the 
microtubule granule net\\Urk via another mechanism such as the actin-
myosin contractile system. Phagolysosorne formation could then occur 
by way of either passive collisions of the phagosorne with the 
microtubule-associated granules, or via granule transp:>rt along the 
microtubule towards the phagosorne (79) • 
After phagocytosis, the neutrophil discharges various lysosornes 
and granules into the phagocytic vacuole. These promote the 
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degradation and neutralization of the engulfed particle or organism 
(48,61,84). Neutrophils contain tw types of granules. Primary or 
azurophilic granules contain hydrolytic enzymes, myeloperoxidase, 
lysozyme, elastase, and cationic proteins. Secondary or specific 
granules are smaller, stain i;oorly, are more numerous in the mature 
neutrophil, arid contain lactoferrin and lysozyme. During the process 
. of engulfment and digestion of microorganisms, secondary granules fuse 
with the forming phagosomes and discharge their contents. Thus 
lactoferrin and lysozyme can escape the neutrophil membrane. Primary 
granules fuse later, with completed phagosomes, so their contents stay 
within the phagolysoscme (14). Following phagocytosis of bacteria, 
neutrophils usually disrupt and die, releasing their lysosomal enzymes 
(80) • 
Phagocytosis results in a burst of oxidative metabolism, causing 
the formation of highly reactive oxygen intermediates such as 
superoxide anion, hydrogen peroxide, hydroxyl radical, and probably 
singlet molecular oxygen. Simultaneously, the granules are discharged 
into phagocytic vacuoles. These tw processes are essential for 
killing ingested microorganisms (48,51,61,84,92). The neutrophil has 
oxygen-dependent and oxygen-independent antimicrobial systems. The 
oxygen-dependent system includes the myeloperoxidase-independent 
systems (hydrogen peroxide, superoxide anion, hydrogen radical, 
singlet oxygen) and the myeloperperoxidase-mediated systems (hydrogen 
peroxide and an oxidizable co-factor such as iodine). The oxygen-
independent antimicrobial system includes acid conditions within the 
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phagosome, lysozyme, lactoferrin, and granular cationic proteins 
(14,48,61,75,80,84). oxidative metabolism or the respiratory burst is 
a metabolic pathway of the neutrophil which results in the formation 
of highly reactive microbicidal agents. These agents are formed by 
the partial reduction of oxygen. /'illy perturbation of the neutrophil 
membrane, such as contact with a microorganism, stimulates the 
respiratory burst (14,51). The mechanism of the respiratory burst is: 
(1) particle contact with the neutrophil membrane activates NADPH 
oxidase which catalyzes the one-electron reduction of molecular oxygen 
to superoxide anion, (2) two molecules of superoxide anion canbine 
sp:intaneously with tl>ID protons to form hydrogen peroxide, (3) 
myeloperoxidase is dep:>sited by degranulation into phagosomes where in 
the presence of hydrogen pe'oxide and a halide such as iodine it 
catalyzes microbicidal reactions, (4) superoxide anion escaped fran 
the phagosane is reduced to hydrogen peroxide by superoxide dismutase 
and the hydrogen peroxide is detoxified by the catalase and 
glutathione-peroxidase-glutathione reductase systems, (5) the NADP+ 
formed by NADPH oxidase and glutathione systems is converted back to 
NADPH by the hexose monophosphate shunt (14,48). 
The fixation of inorganic iodide to bacteria has been shown to be 
a major mechanism by which the neutrophil kills bacteria (10,48,84). 
This iodination reaction reflects a canplex sequence of events. 
Phagocytosis of the opsonized particle is associated with the 
formation of hydrogen peroxide by the neutrophil with the discharge of 
myeloperoxidase into the phagosane from adjacent azurophil granules. 
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When iodide is oxidized by myeloperoxidase and hydrogen peroxide in 
the presence of a suitable iodine acceptor molecule such as the 
tyrosine residues of protein, iodine-carbon bonds are formed (49). 
The neutrophil is usually regarded as a cell whose sole function 
is to recognize, ingest and kill invading microorganisms, but the 
neutrophil also has the capacity for antibody-dependent cell-mediated 
cytolysis (ADCC)· (12). Although ADCC is usually considered to be the 
province of mononuclear cells, when the tw::> types of cells are 
canpared, the neutrophil has been shown to be as effective as 
mononuclear cells in mediating ADCC (12,22,53). The mechani.sm of the 
cytolytic effect is unclear, but it has been shown that the formation 
of reduced oxygen radicals, which normally takes place during · 
phagocytosis, is important (5,12). Experimentally, target cell 
specificity can be achieved by coating the target cells with specific 
antibody (.8,53). Rosettes are formed as the effector neutrophils bind 
to the target cells in a divalent cation-dependent process (8,22). 
Little is known about neutrophil ADCC after rosette formation, and no 
particular neutrophil constituents have been definitely associated 
with the cytotoxic event (8). In ADCC, non-immune Fe receptor-bearing 
leukocytes bind and destroy antibody-coated target cells (53). 
Available evidence supports the following sequence of events in 
neutrophil ADCC: neutrophils attach to antibody-coated target cells in 
a divalent cation-dependent process that involves surface Fe 
receptors; perturbation of the neutrophil plasma membrane activates a 
cellular oxidase which causes the formation of toxic products that 
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damage the target cell (3). Although release of granular comp:inents 
might also occur, no evidence for the involvement of the 
myeloperoxidase system or granular cationic proteins has been· found 
( 8) • 
Neutrophil ADCC does not require canplement synthesis, de novo 
protein synthesis, or DNA replication. The activity is time and 
temperature dependent, and requires close proximity between effector 
cell and target cell (22). Surface receptors on the effector cell for 
the Fe i;:ortion of the immunoglobulin molecule are necessary for 
cytolysis in neutrophil ADCC (15,22,53,78). The same requirement for 
Fe receptors is necessary for lymphocyte~ and monocyte-mediated ADCc· 
(22). Neutrophil ADCC requires larger amounts of target cell-bound 
antibody than lymphocyte- o~ monocyt~mediated ADCC (12,53,78). In 
human leukocyte ADCC for both erythroid and tumor target cell types, 
neutrophil ADCC requires 100 times more target cell-bound antibody 
than does ADCC by lymphocytes and monocytes (53). Although the 
mechanism for neutrophil ADCC is not known, it appears that the 
metabolic burst is essential for maximal ADCC (8) , oxygen radicals 
play an essential role .(5), and neutrophil mediated cytolysis can be 
modulated by intracellular cyclic adenosine 5'-monophosphate (cAMP) 
levels (22). 
Both monocytes and neutrophils reduce oxygen for the production 
of superoxide and hydrogen peroxide during phagocytosis, and the 
processes of ADCC, phagocytosis, and i;:ost-phagocytic events are 
intimately correlated. Under anaerobic conditions, ADCC by human 
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monocytes and neutrophils is approximately 50% reduced, but 
phagocytosis and degranulation are unaffected (5) • 
In neutrophil ADCC, experiments with autonomic agonists and 
inhibitors suggest a cyclic nucleotide-dependent control mechanism. 
Increased neutrophil cAMP suppresses and increased c:Gl'IP enhances 
cytolytic activity. The inhibition of neutrophil ACCC by colchicine, 
an inhibitor of microtubules, suggests that microtubules may be 
important, but inhibitors of protein synthesis, nucleic acid 
synthesis, or complement do not depress neutrophil ADCC (22) • B-
adrenergic agonists, aminophylline, cholera toxin, and dibutyryl cAMP 
inhibit neutrophil-mediated ADCC. A neutrophil-to-target-cell ratio 
of 0.25:1 is effective in neutrophil-mediated ADCC. Using51cr-labeled 
target cells, release of 51cr begins in 30 minutes and becomes maximal 
at ·1 to 2 hours. Neutrophil ACCC is inhibited by the glycolytic 
inhibitors, iodoacetamide, fluoride, and 2-<leoxyglucose, with the 
effect of the latter reversed by excess glucose. Since energy 
production (ATP) by the neutrophil largely depends on glycolysis, this 
suggests an energy requirement, presumably in the form of ATP, for 
cytotoxicity (8). In a microcytotoxicity assay, the antibody 
requirement for cytolysis was further substantiated by the absence of 
cytotoxicity by neutrophils toward nonantibody-coated "innocent 
bystander" cells. In "innocent bystander" experiments, no evidence 
for a soluble mediator of target cell lysis was found for effector 
leukocytes. Lysis was induced by neutrophils in the presence of 
antiserum, and their activity was greater than that of equivalent 
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numbers of mononuclear cells (53). Considerable ADCC activity was 
found in the lymphocyte and neutrophil cell populations (44). 
The neutrophils circulating in peripheral blood are derived from 
granulocytic precursors in the hernopoietic marrow. At the time when 
the mature neutrophils are released into circulation, they are 
generally believed to be terminally differentiated end products, 
. devoid of biosynthetic capacity. However, Granelli-Piperno et al. 
have shown that human peripheral blood neutrophils synthesize RNA and 
proteins during short term culture, and this synthesis can be 
modulated by low concentrations of glucocorticoids (29) • 
Stress and Neutrophil Function 
Stress is a term used to describe a wide variety of external 
influences on an animal (71). It can increase susceptibility to 
disease and has long been associated with the occurrence of infectious 
disease (71,75). The increased susceptibility to disease caused by 
stress is partially due to alterations in immune function (71). 
Stressful conditions in cattle include weaning, transportation, 
handling, castration, dehorning, parturition, forced exercise, 
mastitis, diarrhea, extreme weather conditions, and pain (75). An 
important response of the body to stress is the release of 
adrenocorticotropic hormone (ACTH) frorn the anterior pituitary gland 
which in turn stimulates the adrenal cortex to increase cortisol 
(hydrocortisone) secretion, resulting in elevated blood cortisol 
levels (71,75,76). Physiologic increases of plasma cortisol in 
response to stress is an important factor in the pathogenesis of 
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infectious diseases, including "shipping fever" or the bovine 
respiratory disease complex (BRO), the most costly of all diseases of 
feedlot cattle in the United States (75,76). Increased plasma 
cortisol levels in cattle decrease the ability of neutrophils to leave 
the circulatory system, enhance neutrophil randan migration, and 
decrease the myeloperoxidase catalyzed reaction by neutrophils. This 
alteration of neutrophil function may be enough to give infectious 
agents time to colonize and produce disease before host defense 
mechanisms can bring them under control (71). 
Glucocorticoids and Neutrophil Function 
Clinical observations indicate that glucocorticoids can be 
detrimental to host defense mechanisms. Defining the specific 
effects of glucocorticoids, especially cortisol, on the immune system 
would help define the pathogenesis of stress-induced 
immunosuppression. The neutrophil is the phagocytic cell type which 
has received the most study in relation to cortisol effects (71). 
Natural as well as synthetic glucocorticoids are used extensively in 
bovine medicine (72,75). Dexamethasone is a potent glucocorticoid 
which is. administered to cattle for the induction of parturition, the 
alleviation of physiological udder edema, the reduction of 
musculoskeletal inflammation, and the treatment of ketosis. 
Dexamethasone can cause recrudescence of infectious bovine 
rhinotraceitis virus (IBR), predisposition to a fatal viremia in 
bovine viral diarrhea virus infected calves, and a more severe disease 
course in cattle already suffering from bronchial pneumonia (72). The 
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inhibition of neutrophil-mediated ADCC may allow multiplication of !BR 
virus which has been recrudesced by administration of dexamethasone 
(71). The potentiation of infectious processes indicates that 
dexamethasone treatment suppresses the bovine immune system (72,75), 
and the concurrent administration of effective antibacterial agents is 
often recommended because of this association of glucocorticoids with 
exacerbation of infectious disease processes (75). 
Glucocorticoids decrease levels of circulating peripheral 
lymphocytes and immunoglobulins, inhibit mitogen- and antigen-induced 
blastogenesis of cultured lymphocytes, and decrease bactericidal 
activity of granulocytes and other phagocytic cells (15). Neutrophils 
from dexamethasone-treated cattle display enhanced random migration 
under agarose and impaired ingestion of Staphylococcus aureus, 
nitroblue tetrazolium (NB~) reduction, chemiluminescence, iodination, 
and ADCC. Dexamethasone also suppresses mitogen-induced bovine 
lymphocyte blastogenesis (72). The decreased margination and 
migration of neutrophils into the tissues is probably related to the 
observation that glucocorticoids cause a decreased "stickiness" of the 
neutrophil membrane (71) • 
The most direct approach to evaluating the effects of cortisol on 
the immune system is to administer ACTH. The alterations in immune 
function can then be assumed to result from increased plasma cortisol 
concentrations. Cortisol is a relatively weak glucocorticoid and may 
induce subtle changes in immune function that are important in vivo 
but are below the limits of sensitivity of assay systems. 
\ 
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Administration of ACTH causes a·neutrophilia in cattle, indicating 
that cortisol reduces the rate· of efflux of neutrophils from the blood 
into the tissues. This neutrophilia usµally occurs without an 
increase in band or other immature f6rms ·anct is due to an increased 
influx of neutrophils from the bone mar~ow storage p::>al, decreased 
margination of neutrophils, and a decreased egress of neutrophils from 
the circulation into the tissues (71). Random migration of 
neutrophils is enhanced by in vivo AC'.CH treatment and the neutrophil 
iodination reaction is significantly impaired, but there is no effect 
9n Staphylococcus aureus ingestion, NBT reduction or ADCC (76). Since 
ACTH administration does not inhibit the oxidative metabolism of the 
·neutrophil, the inhibition of the myeloperoxidase reaction is probably 
due to an inhibition of degranulation, which is dependent upon normal 
microtubule function (71). 
Gl._ucocorticoid action classically depends on the combination of 
the steroid with a cytosolic receptor protein and the translocation of 
this drug-receptor complex to the nucleus (l,18,43). In the nucleus, 
by regulating transcription, hormone-receptor complexes stimulate the 
synthesis of particular kinds of messenger ribonucleic acid (rnRNA) 
that, in turn, results in synthesis of specific proteins that mediate . 
the hormone effects (17,57). Many effects of glucocorticoids are 
blocked or counteracted by inhibitors of RNA synthesis. Timed 
addition of inhibitors shows that the period of sensitivity to 
inhibitors of RNA synthesis coincides with the early phases of hormone 
action. This precedes the appearance of the hormone effect and the 
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period of sensitivity to inhibitors of protein synthesis. It has been 
hyp:ithesized that glucocorticoids induce certain proteins by 
increasing the rate of transcription of the appropriate mRNA (57). 
Reduction of Fe receptor numbers on neutrophil cell surfaces 
could explain the suppressive effects of glucocorticoids on 
phagocytosis (15). It has been suggested that corticosteroids inhibit 
the· interaction of IgG sensitized erythrocytes with the neutrophil Fe 
receptor. The inhibitory effect is dependent on the presence of 
steroid before adherence, and is reversible and dose-dependent. It 
was shown that once sensitized erythrocytes were attached to the 
neutrophil membrane, steroids were unable to cause displacement (50). 
Glucocorticoids inhibit expression of the Fe receptor on the human 
promyelocytic cell line HL-QO, but do not cause increased cell death, 
reduced proliferation or a general reduction in protein synthesis. 
After a 48 hour incubation of a human promyelocytic cell line in 1 Ul>l 
cortisol, Fe receptor sites were reduced from 14,400 to about 8,000 
per cell. Dexamethasone gave a half maximal resp:mse at lOu M, and in 
both cases the numbers of Fe receptor sites returned to normal within 
48 hours of removal of the steroid (15). TWo criteria have been 
applied for identification of cells with glucocorticoid receptors. 
The first is for a metabolic or morphologic effect induced by 
cortisol, corticosterone, dexamethasone, prednisolone, or other 
steroids with recognized glucocorticoid activity, at concentrations of 
about 1 ug/ml or less. The second is evidence for specificity of 
glucocorticoids, that is, they produce effects with significantly 
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higher activity than non-glucocorticoids. The effective concentration 
should not grossly exceed plasma levels of free hormone seen 
physiologically (57)'. 
Corticosteroids are capable of reducing lysosomal enzyme release 
from neutrophils exposed either to a variety of phagocytosable 
particles or to innnune reactants deposited on non-phagocytosable 
surfaces (26). By preventing release of "sticky" specific granule 
products, corticosteroids would eliminate some of the factors such as 
lactoferrin and other acidic products which contribute to and sustain 
granulocyte adhesion (64). Release of lysosomal enzymes follows 
fusion between the membranes of lysosomes and those of phagocytic 
vacuoles or the cell itself. Inhibition of lysosomal enzyme release 
and superoxide production may explain, in part, both the 
antiinflammatory actions of steroids and their deleterious effects on 
host defenses (26) • 
When comparing results obtained in an in vitro system to an in 
vivo situation, the concentration of glucocorticoids, the form of the 
glucocorticoid, the incubation time, temperature, composition of the 
media, and the various cell types present must be considered. For in 
vitro results to have in vivo relevance the concentration of 
glucocorticoid should at least be near pharmacologic plasma levels. 
For in vitro models of the effects of stress on the immune system, 
cortisol should be used at near physiologic levels. For example, 
Fleer et al. found a large discrepancy between the minimal 
concentration of hydrocortisone effective in vitro (0.5-1 ml~ and the 
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much lower plasma concentration found effective during treatment in 
vivo (12.5 uM) for inhibition of monocyte ADCC in human cells (16). 
The form of glucocorticoid used in an in vitro assay may influence the 
results since the molecule may need to undergo in vivo modification. 
for maximum effect. If a succinate form of glucocorticoid is used, 
the succinate must be split off in the liver by an esterase enzyme 
before the drug is active. Spontaneous cleavage of the succinate~ 
under in vitro conditions only occurs slowly. The time of in vitro 
incubation is important because at least some glucocorticoid effects 
require RNA and protein synthesis. The incubation should be conducted 
at physiologic temperature and pH (71) • 
If no effects with the glucocorticoid are observed, it may be 
because there are none or because the assay system lacked the 
sensitivity to detect the effect. The types and proportions of cells 
present in an in vitro system may determine the effects obtained. A 
major problem with assays of immune function involving living cells in 
vitro is significant day to day variability in assay results (71). 
The in vivo effect of glucocorticoids on a particular cell type may be ---
indirectly mediated by products of other cells (71,72). 
Animal species are classified as glucocorticoid sensitive or 
glucocorticoid resistant based upon the relative susceptibility to 
production of lymphopenia. Species vary greatly in their response to 
glucocorticoids. For instance, the rat, mouse, and rabbit are quite 
sensitive to corticosteroids, while man, monkey, and guinea pig are 
relatively resistant. The response of cattle to glucocorticoids is 
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more like that of the corticosteroid-resistant species, but 
differences do exist between glucocorticoid effects in cattle and 
other corticosteroid-resistant species (71). Lymphopenia develops 
when cattle are treated with dexamethasone, but no lyrnphopenia or a 
transient lymphopenia results with ACTH treatment (76). The results 
obtained in other species are informative and provide insight into 
basic mechanisms, but it cannot be assumed that the same effect will 
occur in cattle until it is confirmed by experiments using cattle 
(71) • 
Some workers rep::>rted that in -·itro incubation of neutrophils 
with dexamethasone at a concentration of 10-6 to 5.~ x 10-6 M did not 
impair the phagocytic or bactericidal capacity of human neutrophils 
(55), others reported that a significant impairment of bactericidal 
activity occurred with concentrations of dexamethasome of 10-4 to 10-6 
M (80). However, when dexamethasone was added to human neutrophils in 
vitro in whole blood with concentrations equaling 7 x 10-4 M, hexose 
monophosphate shunt (HMS) activity, ascorbate-induced HMS, 
phagocytosis, and iodination were inhibited. They found that human 
neutrophil migration following direct in vitro incubation with 
hydrocortisone at a concentration of 5 x 10-6 to 2.8 x 10-4 M was 
inhibited, but that enhanced migration was observed at a concentration 
of 5 x 10-7 to 2.7 x 10-6 M (55). In another study, in vitro 
incubation of human neutrophils in 0.08 mg/ml of hydrocortisone sodium 
phosphate was found to decrease the phagocytic activity of those 
neutrophils (34). 
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The in vitro effects of a number of steroids was found to include 
inhibition of both hexose rnonophosphate shunt activity and iodination 
of bacteria. Since inhibition occurred in resting as well as in 
phagocytosing cells 1 the steroids probably were not acting solely ui;:on 
particle ingestion but were affecting an enzymatic reaction. 
Hydrocortisone at a concentration of o. 7 uM suppressed iodination of 
zyrnosan particles (10). Aggregation engendered in vitro by zyrnosan-
activated plasma was inhibited by methyl prednisone and hydrocortisone 
at concentrations that approximated plasma levels that would be 
induced with therapy in man. Dexamethasone was ·found to be almost 
without effect. The relative inefficacy of dexamethasone was not 
explained, but its requirement for dephosphorylation and relatively 
slow cellular uptake may be.involved (32). 
Aggregated granulocytes have been found to disaggregate ui;:on 
addition of corticosteroids with an order of i;:otency of methyl 
prednisone:hydrocortisone:dexamethasone, with a methyl prednisone 
concentration of about 2-3 mg/ml required to effect canplete 
disaggregation. High-doses of corticosteroids can cause 
disaggregation as well as block granulocyte aggregation, and the same 
concentrations alter binding of the synthetic chernotaxin, N-formyl-
methionyl-leucyl-phenylalanine (fMLP}, to its specific receptor on the 
neutrophil surface. This alteration in receptor binding is due 
primarily to a decrease in the association rate constant for peptide-
receptor interaction without significant change in dissociation rate 
or receptor number. Dose-dependent inhibition of binding was observed 
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at corticosteroid concentrations paralleling plasma levels achieved 
with 30 mg/kg intravenous therapy; the order of potency was again 
methyl prednisone:hydrocortisone:d~xamethasone (83). 
Stevenson showed that culture of human mononuclear leukocytes in 
the presence of hydrocortisone results in the appearance in the 
culture medium of a factor which markedly stimulates the migration of 
human neutrophils in vitro. The steroid-mononuclear cell interaction 
is dependent on the duration and temperature of the culture, and on 
the concentration of hydrocortisone. He suggests that an active 
biological process is involved which may be relevant to the 
immunosuppressive action of corticosteroids. Cortisosteroids have 
long been known to depress the immune response, but the mechanism of 
their effect is obscure. Stevenson suggests that an enzymatic 
reaction may be involved, the effect of which can be augmented by 
culturing monocytes in the presence of hydrocortisone. He showed that 
hydrocortisone alone had a direct inhibitory effect on the migration 
of purified neutrophils. Corticosteroids have been shown to inhibit 
the normal responses of macrophages and neutrophils to antigenic 
challenge in vivo, and this study provided evidence both for a direct ---
effect of hydrocortisone on neutrophils, resulting in migration 
inhibition, and for an indirect effect, mediated by monocytes, 
resulting in migration stimulation (87,88). It was found that 
steroid-treated lymphocytes did not produce the factor which gives 
this indirect effect on neutrophils (88). 
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Stevenson's results indicate that a neutrophil migration 
stimulator is produced in vitro by the interaction between 
hydrocortisone and glass-adherent mononuclear leukocytes, of which 
over 95% are derived from blood monocytes. He used l-10 ug/ml of 
hydrocortisone in the medium used for this study. This neutrophil 
migration stimulating factor may be relevant to the in vivo effects of ---. 
hydrocortisone on neutrophil kinetics and immunological 
responsiveness, and may relate to the granulocyte colony-stimulating 
factor also produced by monocytes. Neutrophil migration was 
marginally stimulated by hydrocortisone alone, probably due to the 
reaction between hydrocortisone and the mononuclear leukocytes in the 
migrating cell population, which produces a migration-stimulating 
effect on the migrating neutrophils (88) • 
Stevenson reported that corticosteroid therapy stimulates human 
neutrophil migration in vitro, but the effect is dependent on the 
presence of monocytes in the cell population. The monocytes may have 
reacted with steroid in vitro and subsequently liberated neutrophil 
migration stimulator in the migration chamber (89). It was shown that 
neutrophil migration stimulator is induced only by steroids with 
glucocorticoid activity and that spleen and bone marrow cells also 
react with corticosteroids to produce the neutrophil migration 
stimulating factor. Since the inhibition of protein synthesis during 
culture of steroid-treated monocytes prevented the production of 
neutrophil migration stimulator, the migration stimulating activity 
may therefore reside in a peptide moiety actively synthesized under 
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the influence of corticosteroids (90). Studies on the physical 
characteristics of neutrophil migration stimulator show that it is 
soluble and stable at high and low temperatures, and that its activity 
is reduced by acid and alkali treatment and destroyed by protease. 
Experiments involving dialysis, ultrafiltration, and gel filtration 
chromatography indicate that the molecular weight of the neutrophil 
migration stimulator is between 12,000 and 15,000 (92). 
The results suggest that neutrophil migration stimulator acts by 
inhibiting the assembly of neutrophil cytoplasmic microtubules, an 
effect which may be mediated by cAMP in the same manner as other 
peptide hormones. An enhancement of neutrophil migration is produced 
by colchicine and vinblastine, drugs which inhibit the assembly of the 
microtubules on which the functional activity of neutrophils depends. 
Conversely, deuterium oxide which stabilizes microtubules inhibits 
migration (93). Pharmacological agents which inhibit microtubular 
assembly indirectly by increasing intracellular cAMP also stimulate 
neutrophil migration in vitro. These observations suggest that the 
antiinflammatory activity of glucocorticoids is mediated by a peptide 
hormone which inhibits neutrophil microtubular assembly. Many peptide 
hormones are believed to act by increasing the concentration of cAMP 
within target cells, and this mechanism may also be resµ:insible for 
the inhibitory effect of steroids on phagocytic cells (91). Increased 
intracellular cAMP is associated with microtubular inhibition, and 
isoprenaline, theophylline, and dibutyryl cAMP are also found to 
stimulate "capillary tube" migration by neutrophils (93). 
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Mononuclear Cells 
Freshly harvested monocytes and macrophages will adhere to and 
subsequently spread on a glass or plastic surface (9). There is 
evidence that macrophages are derived from peripheral blood monocytes 
that have undergone further differentiation in tissue. 1'bnocytes in 
culture will mature to become macrophages following 3-7 days in 
culture (86). 1'bnocytes or macrophages are usually maintained in 
stationary culture in glass or plastic petri dishes or tissue culture 
flasks. Tissue culture flasks are preferred for long term cultivation 
because they are not subject to evap:iration (35). It is difficult to 
keep macrophages in suspension for long periods of time without 
extensive aggregation (9) • 
At present, there is no way to obtain a completely pure 
population of monocytes from a mixed-cell suspension. The best 
population that one can obtain is one highly enriched in monocytes. 
Adherence to glass or plastic allows for the separation of mixed-cell 
suspensions into adherent (monocyte-rich) and nonadherent (lymphocyte-
rich) populations. Cell populations should be depleted of red blood 
cells and granulocytes prior to adherence by separation on a Ficoll-
Hypaque gradient. Resultant cells should be counted and adjusted to a 
concentration of 2-4 x 106/ml in medium containing 5-20% fetal bovine 
serum. A one hour incubation period at 37 C with 5% carbon dioxide is 
used for adherence. Weakly adherent monocytes will be lost with this 
short incubation· period. Larger yields require a 20-24 hour 
incubation period. Following incubation, the adherent cell layer 
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should be washed 2-3 times with warm medium to remove the non-adherent 
cells (68) • 
The types of cells contaminating the enriched monocyte population 
vary depending on the source of the original cell suspension. B-
lymphocytes are known to be adherent, but the presence of higher 
concentrations of fetal bovine serum (10-40%) in the medium can limit 
B-cell adherence. Neutrophils are also adherent but survive less 
than 24 hours in culture. Fibroblasts are another cell type which is 
adherent but survives only a short time in culture (68). Everything 
which may come into direct or indirect contact with the m::inocytes must 
be sterile. The pH of the medium should be maintained at 7.2 with 
HEPES or 7.5% sodium bicarbonate. All cultures should be incubated at 
37 C in a humidified atmosphere of from 5-7% carbon dioxide in air. 
Basal media such as MEM or Ml99 are used, supplemented with L-
glutamine, penicillin (100 U/ml), streptomycin (100 ug/ml), and 5-20% 
fetal bovine serum (35) • 
Bovine lymphocytes and monocytes cannot be reliably 
differentiated by light microscopic observation of Wright's-stained 
blood smears (71). "Nonspecific esterase" is the most reliable 
cytochemical marker for macrophage or m::inocyte identification. In 
hematology, nonspecific esterases refer to those enzymes which 
hydrolyze acetate or butyrate esters of alpha-naphtha! or complex, 
higher molecular weight, naphtha! aniline sauer compounds (46). 
M:Jnonuclear phagocytes produce bioactive factors important in 
regulating functions of other cells (9,25). Such factors include 
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colony-stimulating activity, plasminogen activator, canplement 
canponents, pyrogen, lymphocyte-activating factor, and prostaglandins 
(25). Human monocytes produce leukocytic pyrogen (13). Therefore, 
cells within the monocyte/macrophage series play a pivotal role in the 
canpiex mechanisms of host defenses. They originate ontologically in 
the yolk sac, and, in the adult, derive from a common stem cell in the 
bone marrow. The cells undergo a series of developmental steps and 
seed multiple organ systems. They display a broad range of functional 
capabilities, including defense against microbial invaders, removal of 
various forms of debris, participation in the cellular interactions of 
immurioregulatiort, secretion of a variety of bioactive materials, and 
control of neoplastically transformed cells. Cells of the mononuclear 
series are concentrated in ~rgans of the reticuloendothelial system, 
which is represented by the spleen, liver, and bone marrow (25). 
Vadas et al. found that media conditioned by human monocyte-
enriched mononuclear cells stimulated ALCC by neutrophils and 
eosinophils, and the uptake and killing of Candida albicans by 
neutrophils. They found that different factors in the media were 
involved in the neutrophil and eosinophil activation. These factors 
were produced without intentional stimulation of the monocytes, and 
their production was prevented by an inhibitor of protein synthesis 
(94) • 
Yang and Zucker-Franklin have found that diffusates of human 
monocytes markedly decreased the killing function of natural killer 
(NK) ·cells, and diffusates of neutrophils enhanced killing by NK 
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cells. Indanethacin did not abolish the suppressive effect of 
monocyte diffusates, and it did not restore the ability of monocyte 
diffusate-treated NK cells to conjugate with melanana targets (95). 
Arachidonic Acid Metabolism 
Arachidonic acid is a 20-carbon polyunsaturated fatty acid which 
is the precursor of prostaglandins and other metabolites (37). 
Arachidonic acid is widely distributed in mammalian tissues, usually 
incorporated into phospholipids and triglycerides but rarely exists as 
a free fatty acid. Prostaglandin or leukotriene synthesis must, 
therefore, be preceded by liberation of substrate (31,38,86). 
Arachidonic acid is very hydrophobic, so a large portion of it is 
picked up by"the avid lipophilic binding sites on serum albumin (31). 
As in other cell types, there is essentially no intracellular pool of 
free arachidonic acid in neutrophils (86). Arachidonic acid is 
degraded by the so-called arachidonic acid cascade which is comprised 
of two distinct pathways. In one pathway, it is hydroxylated by fatty 
acid lipoxygenase which results in the evolution of such hydroxy acids 
as hydroxyeicosatetraenoic acid (HETE). In the other, it interacts 
with prostaglandin endoperoxide synthetase (also referred to as fatty 
acid cyclooxygenase) , a manbrane-bound multienzyn1e canplex that 
specifically catalyzes the incorporation of molecular oxygen in 
polyunsaturated free fatty acids, thereby generating 15-
hydroxyprostaglandin endoperoxides (PGG2 and PGH2 if the substrate is 
arachidonic acid). The liberation of free arachidonic acid causes 
evolution of prostaglandin endoperoxides and the subsequent formation 
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of prostaglandins, thromboxanes, prostacyclins, and a multitu:le of 
other arachidonic acid metabolites depending on the system under 
investigation (31,37). 
Arachidonic acid metabolism generates three families of compounds 
with biological activities. The synthesis of tw::> of these, the 
prostaglandins and the thromboxanes, is initiated by the 
cyclooxygenase, and the synthesis of the leukotrienes is initiated by 
the lipoxygenase enzyme. The relative importance of each of these 
pathways depends on the cell source. In some cells, such as 
platelets, arachidonic acid is metabolized by both pathways, while in 
other cells, such as neutrophils, the metabolism of arachidonic acid 
proceeds predominantly through the lipoxygenase pathway (11,36,43). 
Arachidonate cyclooxygenase. and lipoxygenase products, generated 
either by leukocytes themselves or by other tissues involved in the 
inflammatory response, modulate the fundamental leukocyte functions of 
chemotaxis, phagocytosis, and lysosomal enzyme release. Leukocytes of 
all types contain arachidonic acid metabolizing enzymes which are 
activated by non-specific stimuli such as phagocytosis, immune 
factors, the calcium ionophore A32187, mitogens, endotoxin, or 
lymphokines (37). In most tissues and cells, fatty acids are 
incorporated into larger molecules, such as phospholipids, which form 
an integral part of structures such as cell membranes, and therefore 
prostaglandin synthesis must be preceded by liberation of substrate by 
phospholipase activity (37). Many, possibly all, cells release 
arachidonic acid when they are stimulated with ligands such as 
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hormones, neurotransmitters, and antibodies. The ligands induce 
physical and biochemical events in the membranes, which in turn make 
phospholipids, a major canf()nent of biomernbranes, accessable to 
phospholipases, resulting in the release of arachidonic acid (41). 
The f()ssibility that arachidonic acid metabolites derived fran 
neutrophils may act as regulators of neutrophil function, in 
particular their movement, has interested scientists for several years 
(21). Neutrophils resf()nd to the addition of exogenous arachidonic 
acid and metabolize it through one or more metabolic pathways 
depending on the species (58). When arachidonic acid is added 
simultaneously with the chernotatic peptide fMLP, the normal 
resf()nsiveness of neutrophils to fMLP is inhibited (59). 
Platelet activating fa~tor (PAF) is a phospholipid first 
described as a mediator of anaphylaxis. This factor is released by 
circulating rabbit basophils. PAF is also produced by a variety of 
other cells, including human neutrophils. The action of PAF was first 
restricted to platelet activation, but it also affects neutrophil 
function, including induction of acute neutropenia, the formation of 
intravascular neutrophil aggregates, and the release of lysosanal 
enzymes ( 45) • 
Plasma membranes play an essential role in the establishment and 
the maintenance of the transrnernbrane conditions necessary for the 
transmission of biological signals. The lipid moieties of the plasma 
membrane play, in concert with or independent of the protein 
constituents, an essential role in many of these biological functions. 
28 
various phospholipids modulate the reactivity of several membrane 
enzymes such as the ATPases and the transport activity of ion carriers 
(58). Prostaglandins appear to act by activating adenylate cyclase 
and raising cAMP levels (86) • 
The biological effects of arachidonic acid metabolites are 
species specific. At submicromolar concentrations, exogenous 
arachidonic acid induces chemotactic, secretory, and aggregatory 
responses from rabbit neutrophils, but essentially none from human 
neutrophils. These species differences are thought to be related to 
the endogenous metabolic activity of the various cell populations. 
For example, rabbit peritoneal neutrophils metabolize exogenous 
arachidonic acid to a significantly greater extent than human 
peripheral neutrophils (58)~ 
Leukocytes are involved in all types of inflammatory, immune, and 
anaphylactic responses, and arachidonic acid metabolism apparently 
modulates the development of these reactions. There is extensive 
evidence that leukocytes are the source of inflammatory mediators 
derived from arachidonic acid (37). All types of leukocytes have been 
shown to release a variety of arachidonic acid metabolites in response 
to various stimuli. Leukocytes are present at all stages in the 
inflammatory response, and the leukotriene B4 derived from these cells 
is a putative inflammatory mediator (36). Although in small amounts, 
neutrophils release prostaglandins and thromboxanes during 
phagocytosis (36) , and it has been shown that rabbit peritoneal 
neutrophils synthesize prostaglandins of the E and F series, an 
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activity enhanced by phagocytosis of killed bacteria (37). The major 
products synthesized by leukocyte cyclooxygenase are PGE2 and 
thromboxane B2. Phagocytic leukocytes are more avid sources of 
cyclooxygenase activity than lymphocytes, and both cyclooxygenase and 
lipoxygenase products found in the early stages of experimental 
inflammation are derived from neutrophils. Neutrophils appear to be 
an important source of inflammatory mediators derived from arachidonic 
acid. These oxygenation products can initiate and sustain both the 
vascular and the cellular responses characteristic of inflammation 
(38) • 
One or more of several lipooxygenases initiate a relatively newly 
discovered metabolic pathway for arachidonic acid (52,58). The best 
known of this family are the leukotrienes (30,38,58), a term proposed 
by Bengt Samuelsson for these compounds to indicate that they were 
derived from leukocytes and that they possessed a conjugated triene 
structure (21). Like the prostaglandins, the leukotrienes represent a 
group of potent arachidonic acid oxygenation products whose actions 
appear to be largely inflammatory in nature. However, in view of the 
requirement for recruitment of phagocytic cells to areas of infection 
and the possible involvement of leukotriene B4 in these processes, it 
seems likely that, as with the prostaglandins, the leukotrienes may 
also have important regulatory roles in cell function. The slow-
reacting substance of anaphylaxis is representative of leukotrienes 
and is a mixture of leukotriene D4 and C4 (52). The leukotrienes have 
been shown to be of critical importance in various immediate 
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hypersensitivity reactions, ·to activate mast cells, vascular and 
pulmonary smooth muscle cells and several types of leukocytes (58). 
Since the neutrophil is essential for inflammatory processes, 
involvement of leukotriene B4 in this disease process is indicated 
(52). Leukotrienes are formed within neutrophils, eosinophils, both 
resting and elicited rat peritoneal macrophages, pulmonary 
interstitial macrophages, tissue mast cells and rat and mouse tumor 
cells after stimulation by a lipooxygenas~ependent oxygenation of 
arachidonic acid ·(17,21,54,58). These phagocytic cells are either 
resident or capable of migrating into tissue loci, which places these 
proinflammatory mediators at the sites of their effector functions 
(54). The generated epoxide leukotriene A4 is unstable and converts 
rapidly to leukotriene B4 by enzymatic hydrolysis (30). 
The stereospecificity in the migration, adherence, and secretion 
responses suggest a physiological role for leukotriene B4. Palrnblad 
et al. hypothesized that leukotriene B4 is generated primarily in 
order to recruit neutrophils to an inflammatory area and that 
leukotrienes stimulate neutrophil migration, adherence and secretion. 
As adherence is critical for attachment to endothelial cells, the 
first step in the emigration of neutrophils into the tissues and a 
prerequisite for locanotion, it is noteworthy that leukotriene B4 
affects both of these functions in a similar way. Leukotriene B4 does 
not augment the production of cytotoxic oxygen radicals and causes 
only a marginal extrusion of lysosomal enzymes (65). Leukotriene B4 
is the most chernotactic factor among the lipooxygenase products tested 
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assay systems (66,70). The non-biologically active isomers of 
leukotriene B4 were found to be considerably less active than the 
enzymatically formed leukotriene B4, and 5-HETE and leukotriene C4 did 
not show an effect on chemotaxis (65). It has been shown that 
leukotriene B4 is an order of magnitude more active than the mono-
HETES and has comparable activity to the most i.:otent chemotactic 
agents known, such as.the complement-derived peptide C5a (21). It is 
also a .i;otent aggregator of neutrophils and generator of 
chemiluminescence (54,59,65,66,70). Leukotriene B4 does not affect 
bactericidal mechanisms or oxidative metabolism (65), but does cause 
expression of surface C3b receptors in neutrophils (58). 
Most of the agonist properties of arachidonic acid towards 
neutrophils are attributabl~ to the generation of leukotriene B4 (58). 
It was demonstrated to be a i.:otent chemokinetic and aggregating agent 
for neutrophils, and is chemotactic for neutrophils. Leukotriene B4 
also stimulates the movement of other leukocyte i.:opulations in vitro, 
including guinea-pig eosinophils, rat macrophages and human monocytes. 
It is a .i;otent mediator of leukocyte movement both in vivo and in 
vitro, and its presence in rheumatoid synovial fluid shows that it may 
be an im.i;ortant mediator of inflammation. Leukotriene B4 has similar 
biological properties to the complement-derived peptide C5a but 
differs from this comi.:ound in that it may be produced by the cell ui.:on 
which it acts, suggesting that leukotriene B4 may have an 
intracellular role as a modulator of the action of other stimulators 
of neutrophil function (21). Leukotriene B4 is a i.:otent and 
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multifunctional neutrophil stimulus at nanomolar concentrations (58). 
There is evidence for a role for leukotriene D4 in circulatory 
functions (52). catabolic inactivation of the C-6-sulfidopeptide 
leukotrienes can result from the respiratory burst in human 
neutrophils (54). 
"Classical" chemotactic factors such as fMLP induce, probably in 
a calcil.llll-dependent manner, the generation and release of leukotriene 
B4. The fatty acid will then interact specifically with binding sites 
or receptors on or in neighboring cells. Activating essentially the 
same events as chemotactic factors, leukotriene B4 then increases 
calcium mobilization and cellular resf()nsiveness. The essential 
function of leukotriene B4 would therefore be to be able to amplify or 
stabilize the chemotactic gradients (21,58). There are no specific 
inhibitors of leukotriene B4, but the production may be inhibited, at 
least in part·, by steroids through induction of a phospholipase 
inhibitor (21) which prevents the release of arachidonic acid from 
phospholipids (38). N;Jnsteroid antiinflammatory drugs do not inhibit 
leukotriene synthesis (38). 
Thromboxanes are formed by the degradation of cyclic 
prostaglandin endoperoxides (31). Thranboxane B2 is the major 
cyclooxygenase metabolite generated by neutrophils, monocytes, 
macrophages, and lymphocytes (37). It has been shown that stimulation 
of thromboxane A2 release by agents such as histamine, 5-
hydroxytryptamine, and rabbit aorta contracting substance-releasing 
factor is inhibited by antiinflammatory steroids, and that the steroid 
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potency in this action closely parallels their antiinflanunatory 
activity. The mechanism of steroid action involves the inhibition of 
phospholipase A2 activity, and thus of arachidonic acid release (18). 
The appearance of thranboxane in platelets as a result of arachidonic 
acid metabolism is accanpanied by formation of malonyldialdehyde, a 
cytotoxic degradation product of the prostaglandin endoperoxide 
pentanone nucleus, and hydroxylated fatty acids such as 12-hydroxy-8-
cis,10-cis-heptadecatrienoic acid (HHT) and hydroxyeicosatetraenoic 
acid (HETE). The amount of HHT and HETE or prostaglandins formed in 
any one system is dependent on the relative activity of prostaglandin 
cyclooxygenase and fatty acid lipoxygenase (31). It has been 
demonstrated that a number of HETEs have chemotactic activity for 
neutrophils (21). 
Biologically active prostaglandin products may be involved in 
patho--physiological phenomena such as pain, fever, inflammation, bone 
resorption, fibroblast activation, and thrombosis. These products 
also potentiate the vascular effects of other agonists such as 
histamine or bradykinin. Prostaglandins are able to modify the 
secretion of mediators, such as histamine from human basophils, 
histamine and SRS-A from human lung fragments and, in inflanunation, 
lyrnphokine from lymphoid cells. Some of these phenomena may be 
related to the potency of E-type prostaglandins and prostacyclin to 
stimulate adenylate cyclase (56). Membrane receptors have a specific 
role in inducing the monocyte to secrete prostaglandins, and membrane 
events are p::itent inducers of prostaglandin release (67). 
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The ability of monocytes and macrophages to regulate various 
aspects of immunologic resµ:>nses may depend in part on their release 
of soluble substances such as prostaglandins (27). Macrophages appear 
to be the major site of prostaglandin synthesis in the immune 
resµ:>nse. They produce prostaglandins in resµ:>nse to some phagocytic 
stimuli, as well as in resµ:>nse to lymphokines and other soluble 
activators. Macrophage-derived prostaglandins have a physiologically 
imµ:>rtant inhibitory role in the immune resµ:>nse (86). Macrophage 
phospholipids contain a high proportion of arachidonic acid (60). 
Among human peripheral blood mononuclear cells, only the macrophage 
and not the T lymphocyte has the capacity to synthesize prostaglandins 
or thranboxanes (28). The capacity of the human peritoneal macrophage 
for arachidonic acid metabolism is extensive (20). During 
phagocytosis macrophages produce prostaglandins, 6-oxo-PGFla and 
thromboxanes (23,36). However, Glatt et al. found that PGE2 is the 
main product released from macrophages while other prostaglandins 
could only be obtained in trace quantities (23). In inflammed tissue, 
macrophages are likely to be a main source of inflammatory 
prostaglandins (6). Macrophages are a rich source of cyclooxygenase 
activity but stimulated macrophages release less PGE2 and 6-oxcr-PGFla 
and more thromboxane than do resident macrophages (36,56). This may 
explain why the concentrations of cyclooxygenase products in 
inflammatory exudates decrease as the inflammation progresses (36). 
It is known that inflammatory stimuli induce prostaglandin release 
from macrophages, but it is unclear how they trigger this event 
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(6,60). ~bnocytes in culture release small amounts of PGE into the 
meditnn (37,67). Addition of Fe i;ortions of IgG to human rronocyte 
monolayer cultures results in a marked increase in PGE release, and 
preincubation with indomethacin inhibits the stimulatory effect of 
both Fe fragments and Con A in human cells (67). Prostaglandin E2 was 
found to be the major prostaglandin synthesized in culture by human 
peripheral blood monoeytes (27). Human monocytes produce 
prostaglandins when stimulated with zymosan, endotoxin, or IgG 
fragments (37) • 
The suppression 6f prostaglandin biosynthesis by glucocorticoids 
is by the "classical" pathway. This mechanism requires the occupation 
of a cytosol receptor, interaction of the receptor canplex with the 
nucleus, the formation of new mRNA, and the generation of an enzyme or 
other protein whose specific function is to suppress phospholipase A2 
activity. It was observed that this effect involved a short time lag 
and required intact, metabolically active cells for expression. 
Glucocorticoids can act rapidly to suppress prostaglandin biosynthesis 
by many types of cells. Unlike the aspirin-like drugs, they do not do 
so by inhibiting the cyclooxygenase pathway, but by suppressing the 
release of the fatty acid substrates necessary for biosynthesis, 
apparently by blocking phospholipase A2 (19). 
Antiphospholipase A2 proteins 
Lipomodulin Hirata et al. theorized that the 
antiinflammatory effects of glucocorticoids might reside in the 
capacity of cells to synthesize an antiphospholipase A2 protein (43). 
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Because the products of cyclooxygenase and lip:>xygenase are known to 
have many physiological functions which could lead to inflammatory 
reactions, the presence of a phospholipase A2 inhibitory protein might 
provide a control mechanism for the activity of phospholipase A2 and 
the subsequent availability of its metabolic products. They found 
that a phospholipase A2 inhibitory protein is induced in many cells, 
including neutrophils, by glucocorticoids. Glucocorticoids inhibit 
the release of arachidonic acid fran many cells by inducing synthesis 
of this protein which they named lipomodulin (41). This protein can 
mimic a variety of the biological activities of glucocorticoids such 
as antiinflammation, immunosuppression, and pranotion of cellular 
differentiation (40,43) and can control phospholipase A2-mediated 
events such as lymphocyte mitogenesis, chemotaxis of leukocytes, 
histamine release of mast cells, desensitization of B-adrenergic 
receptors in C6 astrocytana cells, and bradykinin action of 
fibroblasts. Lipanodulin is easily accessible to pronase, which acts 
· on the outer surface of the cells, and appears to be secreted into the 
media, as is often the case with glycoproteins. The conditioned media 
obtained fran such cultures are able to block chemotaxis of 
neutrophils and inhibit pancreatic phospholipase A2 (43) • 
In experiments using lip:>modulin, a highly purified preparation 
inhibited NK and A!JCC activities of human lymphocytes in a dose-
dependent manner. The presence of lip:>modulin during the early period 
of the cytotoxicity assay was necessary to obtain maximal inhibition • 
. The inhibition of NK and ADCC activity was greater when effector cells 
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were treated with lii;:omodulin than when target cells were incubated 
with lipomodulin. As lipomodulin did not block binding of effector 
cells to target cells, it was suggested that lii;:omodulin inhibits the 
cytolytic phase of NK and ADCC after binding, and that phospholipases 
may be .involved in NK and ADCC activities (33). 
Antilipomodulin antibody can block the effects of both 
glucocorticoids and lii;:omodulin, and this is further evidence that 
lipomodulin is a mediator of glucocorticoid effects (40). Antibodies 
against lii;:omodulin were found in patients with rheumatic diseases. 
The titer of antilipomodulin antibodies was related to the severity of 
the disease symptoms (41). 
When thymocytes are stimulated with Con A, lii;:omodulin is 
released into the medium, and it is thought that lipomodulin may be a 
suppressor T-cell inducing factor. In T-lymphocytes, lii;:omodulin 
causes maturation of presuppressor T-cells to suppressor T-cells, a 
process which has been i;:ostulated to be under the control of the major 
histoccmpatibility (MHC) genes. LifQIDodulin bears the I-J determinant 
of the MHC gene complex. Since the glucocorticoid susceptibility of 
prostaglandin formation by mitogen~stimulated lymphocytes has been 
rei;:orted to be controlled by MHC genes, lii;:omodulin might be one of 
the MHC gene products (41) • 
Macrocortin Flower et al. have discovered a.steroid-induced 
factor which mimics the antiphospholipase effects of steroid 
antiinflammatory agents (18) • Antiinflammatory steroids such as 
dexamethasone are able to induce this exogenous inhibitor of 
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phospholipase A2, an effect apparently dependent on de ~ protein 
synthesis ( 31) • The factor was named "macrocortin" , cortin from 
corticosteroids and macro because it was first found to be produced by 
macrophages. Macrocortin is a protein with antiphospholipase activity 
that is released and generated by macrophages and other cells in the 
presence of glucocorticoids. Its antiphospholipase activity enables 
macrocortin to reduce the generation by target cells of 
prostaglandins, and, by implication, other products of fatty acid 
oxidation. This protein has a molecular·weight of 40,000 (19), and is 
a second messenger for the effect of steroids on prostaglandin 
generation (3). Flower found that dexamethasone and hydrocortisone 
induce the release of macrocortin into the peritoneal cavities of 
rats. ACTH also causes the release of these proteins in normal but 
not in adrenalectomized rats. The most likely source of the 
antiphospholipase proteins found in the first series of experiments 
was the resident peritoneal leukocyte, mainly the macrophage (2). 
Macrocortin derived from rat peritoneal leukocytes was later found to 
be very similar to that released from guinea pig lungs. Macrocortins 
from both sources have a number of properties in canmon. Both are 
stable at 70 C for up to 30 minutes but are destroyed by boiling. 
Acidification to pH 2 for 20 minutes results in less than 15% loss of 
activity. There is a substantial loss of activity when material is 
stirred overnight at 4 C with trypsin or papain (3). Flower proposed 
that at least some of the antiiflammatory effects of steroids are 
mediated by the release of macrocortin (15). Peritoneal arid alveolar 
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macrophages from many species, including mouse, guinea pig, rabbit, 
horse and cow, also seem to secrete a protein similar to macrocortin 
(17). Flower suggests that macrocortin is an important second 
messenger for some of the acute antiinflammatory effects of steroids. 
This may be due solely to the ability of the protein to reduce 
eicosanoid synthesis or may be due to another, more subtle, effect 
secondary to inhibition of phospholipase A2. A monoclonal antibody to 
macrocortin was developed, using a crude mixture of lavage proteins 
obtained from steroid-treated rats as the immunizing agent, and this 
antibody reverses the effects of macrocortin (19). The inhibitory 
effect of macrocortin and the effects of steroids are reversed by the 
addition of exogenous arachidonic acid. It is possible that 
macrocortin inactivates membrane phospholipases by interacting with 
the enzyme fran the outside of the cell. Glu::ocorticoids have no 
direct effect on these enzymes, but glucocorticoids can prevent 
prostaglandin and leukotriene synthesis by many intact cells (17). 
Renacortin Rothut et al. report that rat renanedullary 
interstitial cells in culture, when tr~ated with dexamethasone, 
release tw:> proteins which they call "renacortins". These proteins, 
one of 15,000 MW and one of 30,000 MW, are both able to inhibit 
prostaglandin synthesis in untreated cells by an antiphospholipase 
effect. These researchers feel that the variety of cells which 
produce antiphospholipase proteins suggests a general physiological 
phenomenon (77). 
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Nonsteroidal drugs and arachidonic acid metabolism 
N:>nsteroidal drugs, such as aspirin, indomethacin, and 
acetaminophin and other substituted arylacetic acids, are inhibitors 
of fatty acid cyclooxygenase, the first enzyme in the metabolic 
conversion of arachidonic acid to prostaglandins (7,18,23,31). These 
aspirin-like drugs bring about much of their therapeutic action by 
blocking the prostaglandin forming cyclooxygenase and possibly also 
lipoxygenase (17). Kaplan et al. presented evidence that indomethacin 
interferes directly with endoperoxide formation from arachidonic acid 
by interacting with cyclooxygenase in rabbit neutrophils. They 
reported that indanethacin at l.O uM inhibits phospholipase A2 with 
apparent specificity because phospholipases from other sources were 
unaffected at 50 uM (47). Palmblad et al. showed that high 
concentrations of indomethacin reduced the chenotactic effect of fMLP, 
as well as the release of enzymes, whereas lower concentrations, 
inhibiting only the cyclooxygenase, stimulated migration (65). It is 
possible that the selective inhibition of cyclooxygenase by 
indomethacin enhances neutrophil migration by diverting substrate 
towards the production of chemotactic lipoxygenase products (39). 
However, M:Jrley et al. showed that thranboxane generation in monocytes 
is inhibited by indomethacin (56). using an assay system for 
prostaglandin release in vitro as an assay system for antiinflammatory 
drugs, Glatt et al.'-found that both dexamethasone, at a concentration 
of 10-6 to 10-7 M, and indanethacin, at a concentration of 10-7 to 10-
8 M, inhibited prostaglandin release (23). 
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Macrophages and arachidonic acid metabolism 
It is increasingly clear from 'M:>rk in animal systems that 
macrophages are a major source of arachidonic acid metabolites. These 
cells resp:>nd to inflammatory stimuli by the release of arachidonic 
acid metabolites into extracellular spaces. The in vivo site of 
macrophage differentiation seems to be imi;ortant in regulating the 
quantity of arachidonic acid released by macrophages and the 
expression of enzymes for the synthesis of specific cyclooxygenase and 
lip:>xygenase products. Activated macrophages have a reduced capacity 
to release arachidonic acid in resi;:onse to stimuli. Scott et al. 
showed that the capacity for metabolism of exogenously supplied 
arachidonic acid was reduced in activated macrophage p:>pulations, 
implying that the host immune system may regulate the synthesis of 
proinflanunatory lipids by these cells. They found that 3H-arachidonic 
acid supplied in serum-containing medium is readily taken up by 
macrophages under conditions of in vitro cultivation. In the absence 
of a discernable phagocytic or pharmacologic trigger, the incori;:orated 
arachidonic acid is retained in cell phospholipids and insignificant 
amounts are metabolized to cyclooxygenase products. Oxygenation of 
exogenously supplied arachidonic acid yields qualitatively similar 
products to those generated from phospholipid stores following a 
phagocytic challenge, but the relative proi;ortion of products differ 
considerably. After a 20 minute exi;osure of resting cells to 
arachidonic acid, 45% of the products are lii;:oxygenase and 22% of the 
products ate cyclooxygenase. This ratio is the reverse of that 
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released. by phagocytizing cells. HEI'Es and prostacyclins constitute 
the primary arachidonic acid metabolites generated fran exogenous 
arachidonic acid by macrophages (81). 
Neutrophils and arachidonic acid metabolism 
O'Flaherty et al. found that lipoxygenase-dependent products were 
I 
the predaninant derivatives formed by arachidonic acid stimulated 
neutrophils. Incubation with arachidonic acid caused a dose and time 
dependent rise in the numbers of neutrophil aggregates, and blockers 
of arachidonic acid metabolism inhibited the aggregation response to 
arachidonic acid. A neutrophil aggregating activity factor was found 
when neutrophils were preincubated with cytochalasin B, ca++, and 
Mg++, then incubated with arachidonic acid. Since the generation, but 
not the action, of this substance was inhibited by substances which 
inhibit arachidonic acid metabolism, they felt the substance may be 
closely related to, or actually be, an arachidonic acid metabolite. 
Neutrophil aggregating activity factor is stable and appears dependent 
upon the action of lipoxygenase rather than cyclooxygenase. This 
conclusion was reached since other wcrkers had shown that lipoxygenase 
dependent products are the predominant derivatives formed by 
arachidonic acid stimulated neutrophils. In summary, they found that 
neutrophil aggregation proceeds by means of arachidonic acid 
metabolism and the consequential generation of a proaggregating 
activity which mediated the ensuing response (61). 
In another study by O'Flaherty et al., human neutrophil 
aggregation response to 5,12-dihydrohydroxy-6,8,10,14-eicosatetraenoic 
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acid (diHETE) and the chemotactic stimuli csa and fMLP was 
desensitized by preincubating the cells with small amounts of diHETE. 
They found that resi:onsiveness to diHETE appears to be necessary for 
neutrophil aggregation resi:onse to csa and fMLP. Endogenous diHETE, 
which forms rapidly in cells challenged with stimuli, may mediate 
their aggregating actions (62). Neutrophils release granule-bound 
enzymes when challenged under appropriate conditions. They found that 
the human neutrophil degranulation resi:onse to diHETE was ccmpletely 
desensitized by preincubating the cells with small amounts of this 
same fatty acid. The degranulating actions of csa, fMLP, the calcium 
ionophore A32187, l-O-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine 
(AAGPC) , and phorbol myristate acetate (PMA) appeared to be mediated 
by an arachidonic acid metabolite because arachidonic acid 
antirnetabolites blocked the degranulation resi:onse to these stimuli. 
Each stimulus caused resi:onding neutrophils to rapidly metabolize 
their arachidonic acid stores, and arachidonic acid metabolites could 
also cause degranulation of neutrophils (63). 
Addition of dexarnethasone to a stirred suspension of granulocytes 
with or without cytochalasin-B resulted in marked impairment of 
neutrophil aggregation in resi:onse to the chemotactic agent fMLP. 
Dexarnethasone inhibited the ability of fMLP to increase granulocyte 
adherence to endothelium, b~t when human lactoferrin was added to the 
neutrophils exposed to 1.0 rnM dexarnethasone, the cells were able to 
adhere as avidly to endothelium as the cells exposed to either fMLP or 
lactoferrin but free of dexarnethasone, which suggests that 
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dexamethasone has a selective effect on receptor-stimulus coupling. 
At concentrations found previously to inhibit neutrophil aggregation, 
hydrocortisone was found to block the release of lactoferrin to a much 
greater extent than lysozyme or B-glucuronidase fran neutrophils upon 
stimulation with fMLP. The results appeared to show that the products 
of· arachidonic acid metabolism are involved in neutrophil migration, 
aggregation, degranulation, and oxidative metabolism (64). 
Retardation of fusion between neutrophil lysosanal and plasma 
membranes can limit the access of inflammatory and antimicrobial 
lysosanal constituents either to surrounding tissues or to ingested 
microorganisms. The possibility that endogenous 
monohydroxyeicosatetraenoic acid (HETE) derived fran the 
lipoxygenation of arachidonic acid might serve a role in human 
neutrophil migration was examined by studying the effects of depletion 
of the intracellular HETEs on randan migration and chemotaxis. The 
depletion of intracellular HETEs was associated with suppression of 
human neutrophil randcin migration and chemotaxis to several stimuli 
without evidence of cytotoxicity. Maxima~ suppression of migration 
was achieved by a 30-60 minute preincubation with the inhibitors of · 
cyclooxygenase and lipoxygenase while inhibitors of cyclooxygenase 
activity enhanced randan migration and chemotaxis to a lesser extent. 
Incubation with indomethacin at a concentration which inhibits 
cyclooxygenase, but not lipoxygenase activity, significantly enhanced 
the randan migration of neutrophils. 5,8,11,14-eicosatetraynoic acid, 
which inhibits the activity of both lipoxygenase and cyclooxygenase, 
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and nordihydroguaiaretic acid, which preferentially inhibits 
lipoxygenase activity, significantly suppressed neutrophil raridan 
migration and chemotaxis to C5a in a dose dependent fashion with no 
evidence of cytotoxicity assessed by the trypan blue exclusion test. 
It was demonstrated that the suppression of neutrophil randan 
migration and chemotaxis by lipoxygenase inhibitors is associated with 
a concurrent reduction in HETE content in the membranes of human 
neutrophils and is specifically reversed by the addition of purified 
neutrophil 5-HETE (24). 
Hirata et al. found that when rabbit peritoneal leukocytes were 
treated with chemoattractants such as fMLP, degradation of methylated 
phospholipids increased. This fact suggests that the chemoattractant 
activated phospholipase A2, .demonstrating a close association between 
chemotaxis in leukocytes and the degradation of phospholipids by 
phospholipase A2 (42). 
It was shown that release of lysosanal enzymes induced by C3a, 
C5a, and fMLP was inhibited by the arachidonic acid antagonist 
indanethacin. Lipoxygenase products of aracidonic acid are thought to 
be necessary for changes in the neutrophil plasma membrane with 
respect to the' increase in ca++ permeability seen with chemotactic 
factors, or could be interfering with locanotion and degranulation 
because of this blockage. The inhibitory activity of indanethacin in 
this instance is probably a reflection of the capacity of this reagent 
to inhibit phospholipase A2 activity at high concentrations (82). 
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Summary 
The neutrophil is a cell which is very important in host defense 
against invading microorganisms. The neutrophil attacks 
microorganisms by phagocytosis and ingestion and the bactericidal 
mechanisms of lysosomal enzymes, the highly reactive oxygen 
intermediates produced during oxidative metabolism, and fixation of 
inorganic iodide to bacteria. Neutrophil function can be adversely 
affected by stress, administration of glucocorticoids, and products of 
other cell types, including arachidonic acid metabolites. 
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ALTERATION OF NEUTROPHIL FUOCTION BY FACTORS SECRETED BY NORMAL AND 
HYDROCORTISONE-TRFATED MONOCYTES 
Research Objectives 
'.Ille objective of this research was to elucidate the in vivo 
mechanisms of action of glucocorticoids on bovine neutrophil function. 
When dexamethasone (.04 mg/kg body weight) is administered 
intramuscularly (IM) to cattle, several in vitro neutrophil functions 
are adversely affected. Random migratio~ is enhanced and ingestion, 
oxidative metabolism, the activity of the myeloperoxidase-hydrogen 
peroxide-halide antibacterial system (as measured by iodination), and 
the neutrophil's ability to mediate ADCC are all suppressed following 
in vivo dexamethasone treat:Iµent (72). When ACTH is given in vivo, 
causing the serum cortisol level to rise as it does during stress, 
randan migration is enhanced and iodination is suppressed (76). The 
difference in the affects of dexamethasone and ACTH correlates well 
with the observation that dexamethasone is approximately 30 times more 
potent than serum cortisol as an anti-inflammatory agent (75). 
Phagocytosis and killing of bacteria by neutrophils plays an 
important role in the body's defense against invading microorganisms. 
Factors which cause neutrophils to function less effectively leave the 
animal less able to withstand bacterial invasion. The first phase of 
experimentation involved examining the direct effect of 
glucocorticoids on neutrophils. This involved incubating neutrophils 
in hydrocortisone at various concentrations, and evaluating the effect 
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of hydrocortisone on neutrophils by means of in vitro neutrophil 
function assays. The second phase of experimentation involved 
incubating monocyte-enriched, adherent cell cultures with 
physiological to pharmacological concentrations of hydrocortisone. 
The supernatants produced by the monocytes were incubated with 
neutrophils. The effects of the supernatants on neutrophil function 
were determined using in vitro neutrophil function assays. The 
monocytes were found to produce tl'O factors. one factor was found to 
be produced by resting monocytes during the first 24 hours of culture 
in medium which did not contain hydrocortisone. This factor enhanced 
ADCC of neutrophils and had no effect.on the other functions tested. 
A second factor was found to be produced by resting monocytes during 
the first 24 hours of incubation in medium containing 5.0, 0.5, or 
0.05 ug/ml of hydrocortisone. This factor enhanced the randan 
migration of neutrophils, suppressed neutrophil ALCC, and had no 
effect on the other in vitro functions tested. The third phase of 
experimentation consisted of attempting to characterize the t\'.O 
monocyte factors which had been produced. 
Introduction 
This study is part of an ongoing effort to explain in vivo 
effects of glucocorticoids on neutrophil function in cattle. When 
cattle are treated in vivo with dexamethasone or have an elevated 
serum cortisol concentration, several in vitro neutrophil functions 
are suppressed (72,75,76). Following IM injection of dexamethasone 
(0.04 mg/kg body weight), neutrophil randan migration is enhanced, and 
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iodination, NBT reduction and ADCC ar:e suppressed (72). After: IM 
injection of ACTH (200 IU IM) which stimulates the adr:enal cor:tex to 
increase the synthesis and secretion of cortisol, resulting in a r:ise 
in the ser:um cortisol level, r:andom migration is enhanced and 
iodination is suppressed (71,76) •. The difference in r:esults may be 
due to the observation that dexamethasone is known to be 30 times mor:e 
potent than hydr:ocor:tisone (cortisol) as an anti-inflammatory agent 
(75). As glucocor:ticoid ther:apy is common in cattle and stressful 
situations often exist, an explanation for: the mechanism of action of 
glucocor:ticoids in cattle could suggest a method for: overcoming these 
effects. 
Materials and M:thods 
Isolation of neutr:ophils 
Neutr:ophils wer:e isolated as previously described (73). Br:iefly, 
bovine per:ipher:al blood was collected into acid-citr:ate-dextr:ose 
solution and centrifuged at 1000 x g for·20 minutes. The plasma and 
buffy coat were discarded. The packed erythrocytes were lysed by 
brief exposure to hypotonic conditions and the remaining cells, which 
generally consisted of approximately 95% neutrophils, were washed in 
0.015 M phosphate buffered saline solution (PBSS) (pH 7.2), counted 
using a Coulter Counter (Model F, Coulter Electronics, Inc., Hialeah, 
Fla.) and suspended in PBSS at a concentration of 5.0 x 107/ml for 
incubation with test materials and subsequent functional analysis. 
50 
Isolation of monocytes 
Monocytes were isolated from bovine peripheral blocxl which was 
collected into acid-citrate-dextrose solution and centrifuged at 1000 
x g for 20 minutes. The buffy coat was removed by aspiration and 
diluted 1:1 with PBSS. Thirteen ml of this mixture were layered over 
6 ml of 1.077 specific gravity Ficoll-Hypaque (Sigma Chemical Co., st. 
U:mis, 1-b.) and centrifuged at 450 x g for 40 minutes. The mixed 
mononuclear cell (MMC) layer was collected by aspiration, washed twice 
in PBSS at slow speeds to reduce the numbers of platelets in the cell 
button (170 x g for 10 minutes), counted using a Coulter Counter and 
standardized to 5 x 106/ml in medium. This medium was comi;:osed of 
Medium 199 (Gibco, Chagrin Falls, Ohio) with 10% fetal bovine serum, 
1% penicillin-streptomycin solution (KC Biological, Lenexa, Kansas) 
and 2.4% HEPES (KC Biological, Lenexa, Kansas) as buffer. This medium 
was used throughout the experimentation and will be referred to as 
monocyte medium. The isolation and standardization procedures were 
carried out in siliconized glass screw cap tubes, and sterility was 
maintained at all times. 
Immediately following isolation of the MMC, the monocytes were 
separated from the other mononuclear cells by an adherence to plastic 
method (68). Falcon 75 cm2 (Becton Dickinson Labware, Oxnard, Calif.) 
or Corning 25 cm2 (Corning Glass Works, Corning, N.Y.) tissue culture 
flasks were used, and 5 x 106 MMC in l ml of monocyte medium were used 
per 5 cm2 tissue culture flask area. All incubations during this 
experimentation were at 37 C in a humidified atmosphere containing 5% 
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co2• After a one hour incubation, the flasks were washed vigorously 3 
times with warm Ml99 to remove the nonadherent cells, and the medium 
replaced with monocyte medium with or without hydrocortisone (No. H-
4aa1 Cortisol, approximately 98%, Sigma Chemical Company, St. Louis, 
Mo.) for a 24 hour incubation period. The adherent cells were 
determined to be approximately 9S% .monocytes both by morphology and 
latex bead ingestion. Trypan blue exclusion showed more than 99% 
viability. 
Production of monoc:yte supernatants 
Supernatants were produced both by control cells incubated in 
monocyte medium which did not.contain hydrocortisone and by cells 
incubated in monocyte medium which contained hydrocortisone at levels 
which approximated pharmacological to physiological serum levels cs.a, 
a.s, a.as ug/ml). After a 24 hour incubation, the supernatants were 
removed frcm the flasks and frozen in 1 ml aliquots at -7a C until 
used. Flasks were examined for sterility, percentages of monocytes 
present, and viability of the cells. The supernatants frcm any flasks 
which were found to be contaminated were discarded as were the 
supernatants frcm flasks which were found to have low viability. 
Viability after the 24 hour incubation period was generally better 
than 9S% using Trypan blue exclusion. 
Heat and .J2!! treabnent of supernatants 
'lb assess the heat stability of the monocyte-produced factors, 
supernatants with and without hydrocortisone were held at laa C for la 
minutes and cooled to ambient temperature. 'lb assess for low pH 
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stability, supernatants with and without hydrocortisone were brought 
to pH 3 with HCl, held 1 hour, then returned to pH 7.2 with KOH. For 
assessment of high pH stability, supernatants with and without 
hydrocortisone were brought to pH 11 with KOH, held 1 hour, then 
returned to pH 7.2 with HCl. 
Incubation of monocytes with actinomycin Q and puromycin 
Mixed mononuclear cells were isolated from bovine peripheral 
blood, and monocytes were isolated from the MMC by adherence to 
plastic as described above. Following the adherence and washing 
procedures, monocyte medium containing 200 ug/ml of actinomycin D or 
20 ug/ml of puranycin was added to the tissue culture flasks to which 
the monocytes were adhered. The cells were incubated for 1 hour, then 
an amount of monocyte medium equal to the amount of medium already in 
the flasks and containing o.o, 10.0, 1.0, or 0.1 ug/ml of 
hydrocortisone was added to the flasks. This resulted in a final 
concentration of 100 ug/ml of actinomycin D, 10 ug/ml of puromycin, 
and o.o, 5.0, 0.5 or 0.05 ug/ml of hydrocortisone. After a 24 hour 
incubation, the supernatants were collected and frozen in 1 ml 
aliquots at -70 C until used. 
Incubation of monocytes and neutrophils with indomethacin 
M::lnocytes were isolated from bovine peripheral blood and adhered 
to plastic tissue culture flasks as described above. l-bnocyte medium 
containing 100 uM indomethacin was added to the flasks for a 1 hour 
incubation period. Following incubation, the indanethacin-containing 
medium was removed from the flasks, the cultures were washed with warm 
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Ml99, and the medium was replaced with monocyte medium containing a.a, 
5.a, a.5 or a.a5 ug/ml of hydrocortisone. After the cells were 
incubated for 24 hours, the supernatant was removed and stored at -7a 
C in 1 ml aliquots until used. 'lb assay for effects of indomethacin 
on neutrophil function, laa uM indanethacin was included with both 
control media and monocyte supernatants for the 1 hour incubation 
period prior to running the neutrophil function assays. 
Examination of lipid fraction with thin layer chromotography 
The lipid fraction of monocyte supernatants fran monoc:ytes 
prelabeled with 5 ul/ml of 14c-arachidonic acid was extracted by a 
modification of the chloroforni-methanol method of Bligh and Dyer (4) • 
Briefly, 1 ml of monocyte supernatant was added to 6 ml of a 
chloroform-methanol mixture. (1:1, v:v), the mixture stirred, 
refrigerated 18 hours, then centrifuged at 17a x g for la minutes. 
The chloroform phase was removed to a clean glass tube, evap;>rated to 
dryness under nitrogen, and reconstituted in 5a ul of ethyl acetate. 
The lipid-containing ethyl acetate was sp;>tted on silica gel G plates 
(Analtech, Newark, Del.), and the bands separated using n-
Hexane:Ether:Acetic Acid (8a:2a:l, v:v:v) as a solvent (85). The 
barids were visualized by autoradiography, scraped into scintillation 
vials, and the dpn determined for each sample. 
Incubation of neutrophils with supernatants 
One ml aliquots of 5.a x la7 purified neutrophils suspended in 
PBSS were dispensed into siliconized sterile glass screw cap test 
tubes. Two ml of PBSS was added to each tube, the cells were pelleted 
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by centrifugation at 4Sa x g for la minutes and the supernatants ~re 
discarded. One ml of control medium containing a.a, s.a, a.s, or a.as 
ug/ml of hydrocortisone or one ml of the monocyte supernatants which 
also contained a.a, s.a, a.s, or a.as ug/ml of hydrocortisone was 
added to individual tubes. The neutrophils l'iere suspended by using a 
vortex mixer, the screw caps loosened slightly and the tubes incubated 
for l hour. A control tube of neutrophils suspended in PBSS was also 
included. Following incubation, S ml of warm PBSS was added to each 
tube, and the cells ~re washed by centrifugation at 4Sa x g for la 
minutes. The neutrophils ~re resuspended in l ml of PBSS and used 
immediately in the neutrophil function assays. 
Incubation of neutrophils with actinomycin Q and puromycin 
Neutrophils were isolated, standardized, and aliquoted as 
previously described. one ml of control medium containing a.a or s.a 
ug/ml of hydrocortisone or l ml of the m::>nocyte supernatant containing 
a.a or s.a ug/ml of hydrocortisone and also containing laa ug/ml 
actinomycin D or la ug/ml puromycin ·was added to the individual tubes. 
Following a l hour incubation, the neutrophils were washed in PBSS, 
resuspended to S x la7 in PBSS and used in the neutrophil function 
assays. 
Neutrophil function assays 
Random migration under agarose Evaluation of randan migration 
under agarose was performed as previously described (73). The agar 
consisted of bicarbonate-buffered J!.Edium 199 with Hank's salts (Gibco, 
Grand Island, N. Y.) containing a.8% agarose (Phaanindustrie, Clichy, 
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France) , 10% heat-inactivatd (56 C, 30 minutes) fetal bovine serum and 
1% penicillin-streptanycin solution (KC Biologics, Lenexa, Kansas) in 
60 x 15 mm tissue culture grade Petri plates (Falcon, Div. Becton, 
Dickinson and Co., oxnard, Calif.) • Cells were placed into wells cut 
into the agar, and the plates were placed into an incubator with a 
humidified 5% co2 atmosphere. Eighteen hours later the cells were 
fixed with B% glutaraldehyde for 30 minutes, the agar removed fran the 
Petri plate, and the cells adherent to the plastic were stained with 
modified Wright's stain. The area of migration was determined and 
expressed in mm2. 
Staphylococcus aureus ingestion Heat-killed 1251 
iododeoxyuridine-labeled ~ aureus cells are used in the antibody 
facilitated ingestion assay.at a bacteria-to-neutrophil ratio of 60:1 
as previously described (73). 125r-labeled ·~ aureus, bovine anti-s. 
aureus serum and neutrophils (2.5 x 106) in a total volume of o.5 ml 
of Earle's balanced salt solution were incubated together for 10 
minutes at 37 C. The extracellular s. aureus was removed by 
lysostaphin treatment for 30 minutes at 37 C. The cells were washed 
twice in PBSS, and the neutrophil associated radioactivity was 
determined in a gamma counter. The results were expressed as the 
percentage of the total ~ aureus ingested per test tube. 
Iodination The iodination procedure evaluated the activity of 
the myeloperoxidase-hydrogen peroxide-halide antibacterial system as 
previously described (73). The standard reaction mixture for the 
determination of stimulated iodination contained 2.5 x 106 
56 
neutrophils, a.as uCi 1251, 4a runole NaI, and a.s mq of opsonized 
zyrnosan in a.s ml of Earle's balanced salt solution. For the 
determination of resting iodination, the opsonized zyrnosan was 
omitted. The mixture was incubated for 2a minutes at 37 C with end-
over-end rotation. Following the incubation, the reaction was stopped 
by addition of 2.a ml of cold la% trichloroacetic acid. The resulting 
precipitate was washed one additional time in la% trichloroacetic 
acid, and the amount of radioactivity in the precipitate was 
determined· in a gamma counter. The results were expressed as runole of 
NaI/1a7 neutrophils/hour. 
eytotoxicity The ADCC assay was performed utilizing 51cr-
labeled chicken red blood cells (CRBC) as target cells (74). The AJX:C 
reaction mixture contained J,.25 x las 5lcr-labeled CRBC and 1.25 x la6 
rteutrophils (effector:target ratio of la:l) in a.3 ml of Medium 199 
containing 2.5% bovine anti-CRBC serum. The assay was conducted in 
triplicate using a microtiter procedure. Triton-X controls, antibody 
controls, and neutrophil controls were included. After a 2 hour 
incubation at 37 C in a humidified 5% co2 atmosphere, the supernatants 
were harvested by absorption into filter pads using a microtiter 
supernatant collection system. The radioactivity in the fiber pads 
was determined in a gamma counter. The results were expressed as 
percent of specific release, and were calculated using the following 
formula: Percent specific release = (mean cpn test)-(mean cpn 
control)/(mean Triton-X treated cpn)-(mean cpn control) x laa. 'lb 
determine the cytotoxic activity of the neutrophils in the absence of 
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specific antibody, the same procedure was used, except the anti-CRBC 
serl.Iln was replaced with fetal bovine serum. 
Nitroblue tetrazolililil reduction Nitroblue tetrazolil.Iln (NBT) 
reduction by neutrophils was quantitatively determined as previously 
described (73). The procedure was performed in 15 x 100 nnn silicon-
coated glass test tubes. Each reaction tube contained 0.2 ml of NBT 
solution c-2 mg/ml), 5.0 x 106 neutrophils, 0.1 ml of preopsonized 
zymosan, and sufficient Earle's balanced salt solution to bring the 
voll.Ilne to l.O ml. All of the reactants, except neutrophils, were 
added to the tubes and allowed to equilibrate in a water bath at 37 C 
for 15 minutes. The reaction was started by adding neutrophils, and 
was allowed to proceed with periodic shaking for 10 minutes. The 
reaction was stopped by adding 5.0 ml of cold PBSS. The cells and 
insoluble purple formazan formed by the reduction of NBT ~re pelleted 
by centrifugation and suspended in 5.0 ml of pyridine. The pellet was 
dispersed by brief sonic treatment, and the formazan was extracted by 
placing the test tubes in a boiling water bath for 10 minutes. The 
pyridine-formazan was clarified by centrifugation and the OD (580 nm) 
of the supernatant fluid was innnediately determined in a 
spectrophotometer, using a pyridine blank. The results are reµ>rted 
as OD/5.0 x 106 neutrophils/10 minutes in 5.0 ml of pyridine. The 
results represent the average values of duplicate determinations. 
Results 
'lb assess the effects of medium with hydrocortisone and monocyte 
supernatants with and without hydrocortisone on neutrophil function, a 
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fixed number of neutrophils (S.a x la7) was incubated for 1 hour in 1 
ml of the appropriate supernatant or medium. Following the 
incubation, the neutrophils were washed by centrifugation at 4Sa x g 
for la minutes in S ml of PBSS, resuspended in 1 ml of PBSS, and used 
immediately in the neutrophil function assays. 
As can be seen in Fig. 1, the functions of neutrophils incubated 
in supernatant from untreated monocytes were found to have an enhanced 
ability to mediate ADCC. Supernatant from untreated monocytes did not 
significantly affect the other neutrophil functions. Neutrophils 
incubated in monocyte supernatant containing 5 ug/ml of hydrocortisone 
were found to have enhanced randan migration, and suppressed ability 
to mediate ADCC when compared to neutrophils incubated in supernatants 
from untreated monocytes. The other functions were not affected. 
Neutrophils incubated in medium containing S ug/ml hydrocortisone also 
had enhanced random migration, but not to the extent of those 
incubated in hydrocortisone-containing monocyte supernatant. 
Figs. 2 and 3 show the results obtained with ADCC and randan 
migration assays when 3 dilutions of hydrocortisone were contained in 
the medium used to incubate neutrophils and in the medium used to 
produce inonocyte supernatants. Both the ADCC suppression and random 
migration enhancement were found to be affected in a concentration-
dependent manner. The enhancement of ADCC by monocyte supernatant was 
blocked by incubating the monocytes in s.a or a.s ug/ml of 
hydrocortisone but not by a.as ug/ml of hydrocortisone. Randcln 
migration was enhanced when neutrophils were incubated directly with 
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only the highest dosage of hydrocortisone, however there was 
significant enhancement when both 5.0 and 0.5 ug/ml of hydrocortisone 
are used in the production of monocyte supernatants. There was no 
significant enhancement of random migration when neutrophils were 
incubated with supernatant from monocytes treated with 0.05 ug/ml of 
hydrocortisone. 
Supernatants were prepared from the non-adherent mononuclear 
population in the same way as shown for the adherent population. 
Neutrophils were incubated in these supernatants, and the results 
compared to those from neutrophils incubated in medium with and 
without hydrocortisone. Supernatant from the non-adherent mononuclear 
cell population did not produce these same affects (data not shown) • 
In order to determine whether protein synthesis was required by 
the monocyte to produce the 2 factors found, monocytes were incubated 
with 100 ug/ml actinomycin D (RNA synthesis inhibitor) or lO·ug/ml 
puranycin (protein synthesis inhibitor). These inhibitors were 
contained in the medium with or without hydrocortisone for the 24 hour 
incubation period. Table 1 shows the results obtained when 
neutrophils were incubated in the resultant supernatants and when 100 
ug/ml actinomycin D and 10 ug/ml puromycin were included when 
neutrophils were incubated in untreated monocyte supernatants. 
Protein synthesis was not found to be necessary for production of the 
ADCC enhancing factor by the monocyte nor for the neutrophil to 
respond to it. However, it was found that protein synthesis was 
required by the neutrophil for response to the ADCC suppressing and 
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randcrn migration enhancing factor. It could not be determined if 
protein synthesis was required for the monocyte to produce this factor 
because the actinomycin D and puromycin were still in the monocyte 
supernatant when it was put on neutrophils. 
Table 2 shows the results obtained when neutrophils were 
incubated in monocyte supernatants which had been heat- or pH-treated. 
Heat treatment destroyed the PJX:.C enhancing activity found in 
untreated monocyte supernatants. The enhancement of random migration 
of ne~trophils incubated in supernatants from hydrocortisone-treated 
monocytes was reduced when the supernatants were heat-treated. Both 
acidifying and alkalinizing supernatants frcrn untreated monocytes 
somewhat reduced the ADCC enhancement. Alkalinizing supernatants from 
hydrocortisone-treated monocytes reduced the enhancement of randan 
migration to a small extent, but acidifying these supernatants did not 
' affect their ability to enhance randan migration. 
Because the monocyte-produced ADCC enhancing factor did not 
appear to be a newly-synthesized protein and arachidonic acid 
oxidation products are important in initiating and propagating 
inflammation, the effect of hydrocortisone on arachidonic acid 
metabolism of monocytes was examined. Table 3 contains the results 
obtained when monocytes or neutrophils were treated with, 100 uM 
indomethacin. Supernatants both with and without hydrocortisone fran 
monocytes preincubated with indanethacin greatly enhanced the 
neutrophil's ability to mediate PJX:.C. When neutrophils were incubated 
with indanethacin and in untreated monocyte supernatants, the ability 
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of neutrophils to mediate ADCC was only slightly enhanced. 
Because the indomethacin inhibition studies suggested that 
arachidonic acid metabolism might be involved with ADCC enhancement, 
the monocyte supernatants were examined for arachidonic acid and its 
metabolites, The lipid fraction was extracted fran supernatants 
produced fran monocytes prelabeled with 14c-ru:achidonic acid, thin 
layer chromatography was used, and the bands visualized with 
autoradiography. Six bands were found. Bands 2-5 contained 98% of 
the radioactivity and are shown in Fig. 4. Band 4 canigrated with the 
arachidonic acid standard and is significantly increased in 
supernatants fran monocytes incubated with hydrocortisone. Bands 2 
and 3 show significantly higher amounts of radioactivity in the 
supernatants fran monocytes.incubated without hydrocortisone. 
Discussion 
Fig. 5 'depicts in simplified form the results drawn fran the data 
so far. The monocyte incubated in medium. produces a factor 
tentatively called monocyte-produced ADCC enhancing factor (MAEF) 
which increases ADCC in neutrophils but does not affect the other 
functions evaluated. RNA and protein synthesis are not required for 
production of the factor by the monocyte or resi;:onse to it by the 
neutrophil. The monocyte incubated with hydrocortisone produces a 
factor tentatively called hydrocortisone-induced monocyte factor 
(HIMF) which stimulates production of protein in neutrophils resulting 
in suppression of ADCC and enhancement of random migration. When HIMF 
is inhibited, MAEF is again expressed," suggesting MAEF is also 
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produced by the hydrocortisone-treated monocyte. 
The results show that resting monocytes produce a substance 
(MAEF) during the first 24 hours of culture which when incubated with 
neutrophils for 1 or 3 hours (results shown for 1 hour incubation 
only) causes an enhancanent of ADCC by these neutrophils but has no 
effect on the other neutrophil functions tested. Incubation of the 
neutrophil with actinanycin D or puromycin at the same time as 
incubation with monocyte supernatant does not prevent ADCC enhancement 
by the neutrophil. Preincubating monocytes with actinanycin D or 
puranycin for 1 hour before adding the incubation medium did not 
prevent the synthesis of this product, therefore this product is not a 
newly-synthesized protein but may be a preformed protein. Protein 
synthesis by the neutrophil.is apparently not necessary for this 
factor to affect the neutrophil. 
This ADCC enhancing factor or MAEF may be an arachidonic acid 
metabolite. Preincubation of the monocyte with 100 uM indomethacin 
not only did not suppress the synthesis of this substance, but 
apparently enhanced its production (Table 3). Indomethacin inhibits 
the cyclooxygenase pathway at low doses and both the cyclooxygenase 
and lii:;oxygenase pathways at high doses in other species (37), but it 
is not known whether or not this is true in the bovine. Possibly only 
the cyclooxygenase pathway was inhibited. Indomethacin (100 uM) 
enhanced production of MAEF and may have enhanced production of 
lii:;oxygenase products. I.eukotr ienes and HETEs, lip:ixygenase 
metabolites, are known to be aggregators of neutrophils (61,62,70), an 
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event which occurred if the neutrophils were incubated with the 
rnonocyte supernatants for longer than l hour (results not shown). The 
results indicate that MAEF is not a cyclooxygenase product, may be a 
lif()xygenase product, or it may not be an arachidonic acid metabolite 
at all but a product whose production is regulated by arachidonic acid 
metabolism. After the indomethacin preincubation of rnonocytes, the 
supernatant produced did not have either an enhancing or suppressive 
effect on neutrophil random migration. 
1-bnocytes in culture medium containing hydrocortisone produce a 
factor (HIMF) during the first 24 hours of culture which causes an 
increase in neutrophil random migration and a suppression of 
neutrophil ADCC. The neutrophil must be able to synthesize proteins 
in order for the effects to.be expressed. Because the actinomycin D 
or puromycin used to preincubate monocytes were still present in the 
supernatant when it was used to incubate the neutrophils, it could not 
be determined if protein synthesis by the monocyte is necessary for 
production of HIMF. When neutrophils were preincubated with 
actinomycin D or puromycin and when monocytes were preincubated with 
the RNA and protein inhibitors the effects of HIMF were lost, and thus 
it could be determined that protein synthesis was necessary for the 
neutrophil to resrond to HIMF. The hydrocortisone-treated monocyte 
continues to produce MAEF, the neutrophil ADCC enhancing factor. HIMF 
seems to override the effects of MAEF. When the resronse to HIMF is 
eliminated by inhibition of RNA and protein synthesis by the 
neutrophil, MAEF is expressed and ADCC becomes enhanced in neutrophils 
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incubated in supernatant from hydrocortisone-treated cells (Table 1). 
Indomethacin, does not block the production of HIMF (Table 3), thus, 
HIMF is not a cyclooxygenase product. 
The mechanisn of action of glucocorticoids on neutrophil function 
is not clear. various investigators have rep:>rted that 
glucocorticoids cause an inhibition of phospholipase A2 activity in 
the neutrophil membrane resulting in decreased release of arachidonic 
acid from the cell membrane upon stimulation and decreased production 
of arachidonic acid metabolites (1,2,3,19,40,42,43). These 
metabolites are important in initiation and regulation of neutrophil 
function. The results of this study show that hydrocortisone has an 
effect on the arachidonic acid metabolisn of monocytes. Using thin 
layer chromatography, it wa~ shown that there were changes in the 
arachidonic acid metabolites present in the supernatants from 
monocytes incubated with or without hydrocortisone. With the solvent 
which was used here, six distinct bands were found on autoradiography. 
The upper and lower bands showed very little radioactivity and were 
discounted. The four middle bands accounted for more than 90% of the 
radioactivity found. Balld 4 comigrated with the arachidonic acid 
standard, and is therefore probably arachidonic acid. The large 
increase in the amount of arachidonic acid present in the supernatant 
of hydrocortisone-treated monocytes may have been due to decreased 
uptake of free arachidonic acid by hydrocortisone-treated monocytes or 
to an inhibition of arachidonic acid metabolism by hydrocortisone. 
Hydrocortisone significantly reduced the amount of radioactivity in 
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Bands 2 and 3 of the monocyte supernatants. These bands did not 
canigrate with the PGE1 or PGE2 standards used. other metabolites may 
have been present in the supernatant, but failed to separate with this 
solvent system. 
The cani;osition of the monocyte products is not known, nor is it 
known if the monocytes are being stimulated to synthesize the products· 
or if they are releasing preformed substances. The factor released by 
the hydrocortisone,-treated monocytes has characteristics that are 
different fran macrocortin or lipomodulin. These latter two factors 
are produced by a variety of cells when incubated with glucocorticoids 
and are. proteins which inhibit phospholipase A2 (1,2,19,42,43). They 
are similar proteins, very likely the same substance, which have been 
found by tllo'O different groups of researchers. Flower et al. showed 
that de nova protein synthesis is not necessary in lung cells for 
there to be a resi;onse to macrocortin (19). However, neutrophils must 
be able to synthesize proteins in order to resi;ond to HIMF. The 
neutrophil protein induced by HIMF could be the lipomodulin described 
by Hirata et al. Neutrophils are affected after only a 1 hour 
incubation with monocyte supernatant, but Hirata et al. rei;orted that 
neutrophils required a 16 hour incubation with glucocorticoids before 
an effect was noted (43). The neutrophil preparations us.ea by Hirata 
et al. contained 10% mononuclear cells (42).. It may be that the 16 
hour incubation period was needed in order for the monocytes in the 
cell culture to produce a factor which induced lii;omodulin synthesis 
in the neutrophils. An interesting canparison between lipomodulin and 
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our neutrophil-produced factor is that lipomodulin from rabbit 
neutrophils treated with glucocorticoids, inhibited NK and ADCC 
activities of human peripheral blood lymphocytes in a dose-dependent 
manner (33). This effect is similar to the neutrophil ADCC 
suppressing factor induced in neutrophils by HIMF in this study. 
When dexamethasone is given intramuscularly to cattle, the 
function of the neutrophils of those animals is affected. Randc.m 
migration is enhanced, while iodination, NBT reduction and 
cytotoxicity are suppressed. A neutrophilia also results frc.m 
treatment of cattle with steroids (72). When ACTH is given to cattle, 
resulting in an increase in serum cortisol, randc.m migration is 
enhanced, iodination is suppressed, and the other neutrophil functions 
are unaffected. This correlates with the observation that 
dexamethasone. is approximately 3a times more potent as an anti-
inflammatory agent than cortisol (75). The serum cortisol level 
produced by ACTH treatment of cattle has been reported to average 
about a.as ug/ml which falls between the a.s and a.as ug/ml levels 
used in this study (76). The use of dexamethasone-in vivo ors.a 
ug/ml of hydrocortisone in vitro =uld both be considered 
pharmacologic levels of glucocorticoid (72) • 
The in vivo treatment results differ from the in vitro effects we ---
have found. The iodination assay is consistently suppressed by in 
vivo treatment with dexamethasone or ACTH. No effect on iodination 
was found when neutrophils were incubated directly in either 
dexamethasone or hydrocortisone for periods ranging from 1 to 24 hours 
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(only the results from l hour incubation with hydrocortisone are 
shown) • we prop:ise that glucocorticoid effects on neutrophils may be 
mediated by products of other cell types, rather than being direct 
effects on the neutrophil itself. The results presented in this study 
indicate that monocytes may mediate some, but not all of· the 
suppressive effects which glucocorticoids have on neutrophils. 
Further characterization of the tw:J factors described may give insight 
into the mechanism of glucocorticoid suppression of neutrophil 
function. 
Summary 
Hydrocortisone (5.0, 0.5, or.0.05 ug/ml) when incubated for 1.0 
or 3.0 hours with neutrophils isolated from bovine peripheral blood 
had no significant effect on the ability of neutrophils to ingest ~ 
aureus, reduce nitroblue tetrazolium ·(NBT), iodinate protein, or 
mediate antibody-dependent cell-mediated cytotoxicity (AJ:CC) against 
chicken erythrocytes. Randan migration was significantly enhanced by 
the highest concentration of hydrocortisone, but was unaffected by the 
lower concentrations. Bovine monocytes were incubated for 24 hours in 
medium with or without added hydrocortisone (5.0, 0.5, or 0.05 ug/ml). 
Purified bovine neutrophils were then incubated for 1.0 or 3.0 hours 
with the resulting nonocyte supernatant fluids. The supernatant fran 
control monocytes significantly enhanced neutrophil ADCC but did not 
affect the other neutrophil functions evaluated. Supernatants fran 
monocytes incubated with hydrocortisone produced a concentration-
dependent blockage of the monocyte enhancement of neutrophil ADCC and 
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an enhancement of neutrophil randan migration under agarose. The 
other parameters of neutrophil function were unaffected. The results 
indicate that the monocyte may mediate the enhancement of neutrophil 
random migration and inhibition of neutrophil ADCC which occurs in 
glucocorticoid-treated cattle. 
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Fig. 1. Effects of incubation in medimn containing 0.0 or 5.0 ug/ml 
hydrocortisone on various aspects of bovin~ neutrophil functiona 
aResults are expressed as a percent of the value for neutrophils 
incubated.in nEdimn alone (control)+ SEM. n~30. 
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Fig. 2. Effects of incubation in medium or rronocyte supernatant and 
three concentrations of hydrocortisone on bovine neutrophil-mediated 
ruxx;a 
·aResults are expressed as a percent of the value for neutrophils 
incubated in medium alone (control) + SEM. n ~30. 
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Fig. 3. Effects of incubation in medi1.U11 or 111'.Jnocyte supernatant and 
three concentrations of hydrocortisone on bovine neutrophil randan 
migrationa 
aResults are expressed as a percent of the value for neutrophils 
incubated in medi1.U11 alone (control) ± SEM. · n ~30. 
Table 1. Effects of preincubation of neutrophils with inhibitors of RNA and of protein synthesisa 
Neutrophil incubant 
Medium 
Monocyte supernatant 
Supernatant from monocytes incubated 
with Actinomycin D 
with Puromycin 
PMNs preincubated with 
Actinomycin D and supernatant 
Puromycin and supernatant 
AOCC 
o.o ug/ml 
Hydrocortisone 
100 percent 
154.3 + 13.5 
150.9 + 34.4 
133.5 + 34.6 
146.1 + 6.1 
154.9 + 10.3 
5.0 ug/ml 
Hydroc9rtisone 
98.2 + 13.0 
115.7 + 8.2 
133.2 + 33.2 
147.1 + 32.2 
136.2 + 13.3 
157.3 + 9.8 
Random Migration 
O.O ug/ml 
Hydrocortisone 
100 percent 
88.8 + 6.8 
88. 7 + 7. 7 
107.4 + 9.6 
91.1 + 13.l 
75.8 + 6.0 
5.0 ug/ml 
Hydrocortisone 
123.3 + 7.1 
136.7 + 9.7 
90.3 + 7.8 
113.1 + 12.6 
109.4 + 20.2 
103.9 + 11.2 
a Results are expressed as a percent of the value for neutrophils preincubated in medium' alone 
(control) + SFM. n=l8 
_, 
"' 
Table 2 Results of incubation of neutrophils with monocyte supernatants which have been heat- or 
pH-treateda 
ADCC Random Migration 
a.a ug/ml 5~a ug/ml a.a ug/ml 5.a ug/ml 
Hydrocortisone Hydrocortisone Hydrocortisone Hydrocortisone 
Medium laa percent 98.2 + 13.a 10a percent 123.3 + 7.1 
Monocyte supernatant 154.3 + 13.5 115.7 + 0.2 88.8 + 6.8 136.7 + 9.7 
!bnocyte supernatant 
Heat-treated 102.a + 5.3 84.6 + 6.7 98.3 + 2.6 122.4 + 4.8 
pH-11-treated 12a.a + 11.1 la2.7 +la.a 98.7 + la.9 129.5 + 6.8 
pH-3-treated 127.7 + 12.4 laa.1 + 7.4 97.8 + 7.7 14a.3 + 9,4 
a Results are expressed as a percent of the value for neutrophils preincubated in medium alone 
(control) + SEM. n=l8 
_, 
w 
Table 3. Results of incubation of neutrophils with supernatants from monocytes preincubated with. 
indomethacin and of neutrophils incubated with indanethacin and monocyte supernatantffl 
AOCC 
Neutrophil incubant 
1-Edium 
Monocyte supernatant 
Supernatants from monocytes 
incubated with Indomethacin 
o.o ug/ml 
Hydrocortisone 
100 percent 
154.3 + 13.5 
183.4 + 1.2 
Neutrophils incubated with Indomethacin 
and monocyte supernatant 122.1 + 15.5 
5.0 ug/ml 
Hydrocortisone 
98.2 + 13.0 
115.7 + 8.2 
169.o + 0.0 
131.0 + 24 .9 
Random Migration 
o.o ug/ml 5.0 ug/ml 
Hydrocortisone Hydrocortisone 
100 percent 123.3 + 7.1 
88.8 + 6.8 136.7 + 9.7 
90.9 + 7.5 151.1 + 7.1 
75.2 + 4.2 125.9 + 14.7 
aResults are expressed as a percent of the value for neutrophils preincubated in medium alone 
(control) + SEM. n=l8 
..., ... 
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